
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs3.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Tartrate-resistant acid phosphatase (TRAP/ACP5) promotes metastasis-related properties via TGF&#946;2/T&#946;R and CD44 in MDA-MB-231 breast cancer cells - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="D0BD41E4AC192A4500002A81A36E027A.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="bmccanc" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC5602878/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602878/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="BMC Cancer" /><meta name="citation_title" content="Tartrate-resistant acid phosphatase (TRAP/ACP5) promotes metastasis-related properties via TGF&#x003b2;2/T&#x003b2;R and CD44 in MDA-MB-231 breast cancer cells" /><meta name="citation_author" content="Anja Reithmeier" /><meta name="citation_author_institution" content="Karolinska Institutet, Department of Laboratory Medicine (LABMED), H5, Division of Pathology, F46, Karolinska University Hospital, Huddinge, 141 86 Stockholm, Sweden" /><meta name="citation_author" content="Elena Panizza" /><meta name="citation_author_institution" content="Karolinska Institutet, Department of Oncology-Pathology (OnkPat), K7, Research Group Janne Lehti&#x000f6;, Box 1031, 171 21 Solna, Sweden" /><meta name="citation_author" content="Michael Krumpel" /><meta name="citation_author_institution" content="Karolinska Institutet, Department of Laboratory Medicine (LABMED), H5, Division of Pathology, F46, Karolinska University Hospital, Huddinge, 141 86 Stockholm, Sweden" /><meta name="citation_author" content="Lukas M. Orre" /><meta name="citation_author_institution" content="Karolinska Institutet, Department of Oncology-Pathology (OnkPat), K7, Research Group Janne Lehti&#x000f6;, Box 1031, 171 21 Solna, Sweden" /><meta name="citation_author" content="Rui M. M. Branca" /><meta name="citation_author_institution" content="Karolinska Institutet, Department of Oncology-Pathology (OnkPat), K7, Research Group Janne Lehti&#x000f6;, Box 1031, 171 21 Solna, Sweden" /><meta name="citation_author" content="Janne Lehti&#x000f6;" /><meta name="citation_author_institution" content="Karolinska Institutet, Department of Oncology-Pathology (OnkPat), K7, Research Group Janne Lehti&#x000f6;, Box 1031, 171 21 Solna, Sweden" /><meta name="citation_author" content="Barbro Ek-Rylander" /><meta name="citation_author_institution" content="Karolinska Institutet, Department of Laboratory Medicine (LABMED), H5, Division of Pathology, F46, Karolinska University Hospital, Huddinge, 141 86 Stockholm, Sweden" /><meta name="citation_author" content="G&#x000f6;ran Andersson" /><meta name="citation_author_institution" content="Karolinska Institutet, Department of Laboratory Medicine (LABMED), H5, Division of Pathology, F46, Karolinska University Hospital, Huddinge, 141 86 Stockholm, Sweden" /><meta name="citation_publication_date" content="2017" /><meta name="citation_volume" content="17" /><meta name="citation_doi" content="10.1186/s12885-017-3616-7" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC5602878/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC5602878/" /><meta name="citation_pmid" content="28915803" /><meta name="DC.Title" content="Tartrate-resistant acid phosphatase (TRAP/ACP5) promotes metastasis-related properties via TGF&#x003b2;2/T&#x003b2;R and CD44 in MDA-MB-231 breast cancer cells" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="BMC" /><meta name="DC.Contributor" content="Anja Reithmeier" /><meta name="DC.Contributor" content="Elena Panizza" /><meta name="DC.Contributor" content="Michael Krumpel" /><meta name="DC.Contributor" content="Lukas M. Orre" /><meta name="DC.Contributor" content="Rui M. M. Branca" /><meta name="DC.Contributor" content="Janne Lehti&#x000f6;" /><meta name="DC.Contributor" content="Barbro Ek-Rylander" /><meta name="DC.Contributor" content="G&#x000f6;ran Andersson" /><meta name="DC.Date" content="2017" /><meta name="DC.Identifier" content="10.1186/s12885-017-3616-7" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Tartrate-resistant acid phosphatase (TRAP/ACP5) promotes metastasis-related properties via TGF&#x003b2;2/T&#x003b2;R and CD44 in MDA-MB-231 breast cancer cells" /><meta property="og:type" content="article" /><meta property="og:description" content="Tartrate-resistant acid phosphatase (TRAP/ACP5), a metalloenzyme that is characteristic for its expression in activated osteoclasts and in macrophages, has recently gained considerable focus as a driver of metastasis and was associated with clinically ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602878/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5602878/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/16/">BMC Cancer</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/282902/">v.17; 2017</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC5602878
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC5602878/pdf/12885_2017_Article_3616.pdf" class="int-view">PDF (3.1M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/5602878/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/5602878/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="5602878" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5602878%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="N8S7x2PgboJsYRZ0wwwr7vETUS67zRTUaDM1Y3sfUhoM81WkqFfDkMPpsgIKe0Wk">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5602878%2F&amp;text=Tartrate-resistant%20acid%20phosphatase%20(TRAP%2FACP5)%20promotes%20metastasis-related%20properties%20via%20TGF%003B22%2FT%003B2R%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5602878%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602878/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC5602878/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/28915803/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC5602878/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/28915803/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC5602878/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/5602878/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/16/">BMC Cancer</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/282902/">v.17; 2017</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC5602878
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><a href="//doi.org/10.1186%2Fs12885-017-3616-7" title="Link to Publisher's site" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A"><img src="/corehtml/pmc/pmcgifs/logo-bmccanc.png" alt="Logo of bmccanc"><!-- --></img></a></div>
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">BMC Cancer.</span> 2017; 17: 650. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2017 Sep 15. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.1186%2Fs12885-017-3616-7" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1186/s12885-017-3616-7</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC5602878</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/28915803">28915803</a></div></div></div><h1 class="content-title">Tartrate-resistant acid phosphatase (TRAP/<em>ACP5</em>) promotes metastasis-related properties via TGF&#x003b2;2/T&#x003b2;R and CD44 in MDA-MB-231 breast cancer cells</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Reithmeier%20A%5BAuthor%5D" class="affpopup" co-rid="_co_idm140249786045216" co-class="co-affbox">Anja Reithmeier</a>,<sup>#</sup><sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Panizza%20E%5BAuthor%5D" class="affpopup" co-rid="_co_idm140249770096752" co-class="co-affbox">Elena Panizza</a>,<sup>#</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Krumpel%20M%5BAuthor%5D" class="affpopup" co-rid="_co_idm140249784006784" co-class="co-affbox">Michael Krumpel</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Orre%20LM%5BAuthor%5D" class="affpopup" co-rid="_co_idm140249775200352" co-class="co-affbox">Lukas M. Orre</a>,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Branca%20RM%5BAuthor%5D" class="affpopup" co-rid="_co_idm140249779499712" co-class="co-affbox">Rui M. M. Branca</a>,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Lehti&#x000f6;%20J%5BAuthor%5D" class="affpopup" co-rid="_co_idm140249771117664" co-class="co-affbox">Janne Lehti&#x000f6;</a>,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ek-Rylander%20B%5BAuthor%5D" class="affpopup" co-rid="_co_idm140249772348464" co-class="co-affbox">Barbro Ek-Rylander</a>,<sup>1</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Andersson%20G%5BAuthor%5D" class="affpopup" co-rid="_co_idm140249772346096" co-class="co-affbox">G&#x000f6;ran Andersson</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>1</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140249786045216"><h3 class="no_margin">Anja Reithmeier</h3><p><sup>1</sup>Karolinska Institutet, Department of Laboratory Medicine (LABMED), H5, Division of Pathology, F46, Karolinska University Hospital, Huddinge, 141 86 Stockholm, Sweden </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Reithmeier%20A%5BAuthor%5D">Anja Reithmeier</a></div></div><div id="_co_idm140249770096752"><h3 class="no_margin">Elena Panizza</h3><p><sup>2</sup>Karolinska Institutet, Department of Oncology-Pathology (OnkPat), K7, Research Group Janne Lehti&#x000f6;, Box 1031, 171 21 Solna, Sweden </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Panizza%20E%5BAuthor%5D">Elena Panizza</a></div></div><div id="_co_idm140249784006784"><h3 class="no_margin">Michael Krumpel</h3><p><sup>1</sup>Karolinska Institutet, Department of Laboratory Medicine (LABMED), H5, Division of Pathology, F46, Karolinska University Hospital, Huddinge, 141 86 Stockholm, Sweden </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Krumpel%20M%5BAuthor%5D">Michael Krumpel</a></div></div><div id="_co_idm140249775200352"><h3 class="no_margin">Lukas M. Orre</h3><p><sup>2</sup>Karolinska Institutet, Department of Oncology-Pathology (OnkPat), K7, Research Group Janne Lehti&#x000f6;, Box 1031, 171 21 Solna, Sweden </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Orre%20LM%5BAuthor%5D">Lukas M. Orre</a></div></div><div id="_co_idm140249779499712"><h3 class="no_margin">Rui M. M. Branca</h3><p><sup>2</sup>Karolinska Institutet, Department of Oncology-Pathology (OnkPat), K7, Research Group Janne Lehti&#x000f6;, Box 1031, 171 21 Solna, Sweden </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Branca%20RM%5BAuthor%5D">Rui M. M. Branca</a></div></div><div id="_co_idm140249771117664"><h3 class="no_margin">Janne Lehti&#x000f6;</h3><p><sup>2</sup>Karolinska Institutet, Department of Oncology-Pathology (OnkPat), K7, Research Group Janne Lehti&#x000f6;, Box 1031, 171 21 Solna, Sweden </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Lehti&#x000f6;%20J%5BAuthor%5D">Janne Lehti&#x000f6;</a></div></div><div id="_co_idm140249772348464"><h3 class="no_margin">Barbro Ek-Rylander</h3><p><sup>1</sup>Karolinska Institutet, Department of Laboratory Medicine (LABMED), H5, Division of Pathology, F46, Karolinska University Hospital, Huddinge, 141 86 Stockholm, Sweden </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ek-Rylander%20B%5BAuthor%5D">Barbro Ek-Rylander</a></div></div><div id="_co_idm140249772346096"><h3 class="no_margin">G&#x000f6;ran Andersson</h3><p><sup>1</sup>Karolinska Institutet, Department of Laboratory Medicine (LABMED), H5, Division of Pathology, F46, Karolinska University Hospital, Huddinge, 141 86 Stockholm, Sweden </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Andersson%20G%5BAuthor%5D">G&#x000f6;ran Andersson</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140249772675520_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140249772675520_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140249772675520_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140249772675520_ai" style="display:none"><div class="fm-affl" id="Aff1"><sup>1</sup>Karolinska Institutet, Department of Laboratory Medicine (LABMED), H5, Division of Pathology, F46, Karolinska University Hospital, Huddinge, 141 86 Stockholm, Sweden </div><div class="fm-affl" id="Aff2"><sup>2</sup>Karolinska Institutet, Department of Oncology-Pathology (OnkPat), K7, Research Group Janne Lehti&#x000f6;, Box 1031, 171 21 Solna, Sweden </div><div><span class="fm-affl">Anja Reithmeier, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="es.ik@reiemhtier.ajna" class="oemail">es.ik@reiemhtier.ajna</a></span>.</div><div><a href="#article-aaff-info">Contributor Information</a>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div><sup>#</sup>Contributed equally.</div></div><div class="fm-article-notes hide half_rhythm" id="idm140249772675520_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2017 Jun 27; Accepted 2017 Aug 28.</div></div><div class="permissions half_rhythm hide" id="idm140249772675520_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; The Author(s). 2017</div><div class="license half_rhythm">
<strong>Open Access</strong>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<a href="http://creativecommons.org/licenses/by/4.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/licenses/by/4.0/</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<a href="http://creativecommons.org/publicdomain/zero/1.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/publicdomain/zero/1.0/</a>) applies to the data made available in this article, unless otherwise stated.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-count="8" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Additional file 1: Material and Methods: </strong>Additional explanations on Material and Methods including descriptions of gene expression analysis, cell lysis, SILAC labeling, protein extraction for mass spectrometric analyses, protein digestion, Tandem Mass Tag labeling, liquid chromatography tandem mass spectrometric analyses and proteomics database search, protein and phospho-peptide ratios calculation. (DOCX 32 kb)</div><div><a href="/pmc/articles/PMC5602878/bin/12885_2017_3616_MOESM1_ESM.docx" data-ga-action="click_feat_suppl">12885_2017_3616_MOESM1_ESM.docx</a><span style="color:gray"> (32K)</span></div><div class="small guid">GUID: 5FF715AC-4F4D-4997-9865-C41B2B4EE05C</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Additional file 2: Figure S1: </strong>Distribution of unique peptides across fractions generated by HiRIEF separation on IPG 2.5&#x02013;3.7 strips. Number of unique peptides and phospho-peptides identified across fractions in each biological replicate (A) and (B), displayed by number of phosphorylations. Fraction numbering proceeds from the acidic end towards the basic end of the strips. Multiply phosphorylated peptides are identified prevalently in the first 30 fractions in the IPG 2.5&#x02013;3.7 strip. (PDF 148 kb)</div><div><a href="/pmc/articles/PMC5602878/bin/12885_2017_3616_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl">12885_2017_3616_MOESM2_ESM.pdf</a><span style="color:gray"> (149K)</span></div><div class="small guid">GUID: 2BD976D8-12B3-4D46-B003-A4C2F70C922F</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Additional file 3: Figure S2: </strong>Quantitative reproducibility of biological replicates employed for phosphoproteomics and proteomics analysis of TRAP3<sup>high</sup> (Heavy SILAC labeled) and control (Light SILAC labeled) MDA-MB-231 cells. Correlation of log<sub>2</sub> transformed ratio (H/L) values for replicate pairs for phosphoproteomics analysis (A) and standard proteomics analysis (B); Pearson correlation coefficient is displayed. (PDF 2872 kb)</div><div><a href="/pmc/articles/PMC5602878/bin/12885_2017_3616_MOESM3_ESM.pdf" data-ga-action="click_feat_suppl">12885_2017_3616_MOESM3_ESM.pdf</a><span style="color:gray"> (2.8M)</span></div><div class="small guid">GUID: C599CAE8-85CF-4AC4-8D67-B46BB4DB7B6E</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Additional file 4: Table S1: </strong>Phosphorylation sites significantly regulated in TRAP3<sup>high</sup> cells compared to control (ctrl) cells. Unique phosphorylation sites are defined by a sequence window of 15 amino acids centered at the phosphorylated residue. The column &#x0201c;Protein class&#x0201d; describes to which of the examined protein class a protein belongs to. Examined proteins classes include protein kinases, protein phosphatases, ubiquitin and UBL system enzymes and transcription factors. The column &#x0201c;Functional site&#x0201d; describes whether the phospho-site has a known regulatory function based on the information available on the database PhosphoSitePlus. (XLSX 48 kb)</div><div><a href="/pmc/articles/PMC5602878/bin/12885_2017_3616_MOESM4_ESM.xlsx" data-ga-action="click_feat_suppl">12885_2017_3616_MOESM4_ESM.xlsx</a><span style="color:gray"> (48K)</span></div><div class="small guid">GUID: DA5EE578-3D9C-4D9C-B55E-F15853617CBE</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Additional file 5: Figure S3: </strong>Volcano plots representing the selection of proteins significantly regulated upon TRAP knockdown in TRAP3<sup>high</sup> MDA-MB-231 cells. The average log<sub>2</sub> transformed ratio of the three replicates is plotted for each experimental condition. Significantly regulated events are defined by log<sub>2</sub> transformed ratios at least &#x02212;/+3 MAD away from the median and <em>p</em>-values lower than 0.01. TRAP sh2 samples versus scrambled (A). TRAP sh3&#x000a0;+&#x000a0;4 samples vs scrambled (B). (PDF 5171 kb)</div><div><a href="/pmc/articles/PMC5602878/bin/12885_2017_3616_MOESM5_ESM.pdf" data-ga-action="click_feat_suppl">12885_2017_3616_MOESM5_ESM.pdf</a><span style="color:gray"> (5.0M)</span></div><div class="small guid">GUID: 69088855-58FA-44B6-AAA8-7C3FA2D3511F</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Additional file 6: Figure S4: </strong>GO enrichment analyses of genes corresponding to phosphorylation sites significantly regulated upon TRAP overexpression in MDA-MB-231 cells. GO terms enrichment was evaluated for the set of genes corresponding to phospho-sites significantly regulated in TRAP3<sup>high</sup> cells (99 genes) compared to the set of genes identified across all proteomics analyses (9570 genes). Enriched GO terms are displayed by significance of the enrichment (q-value, multiple testing corrected) and fold enrichment. GO Molecular Function enrichment analysis (A). GO Cell Component enrichment analysis (B). (PDF 86 kb)</div><div><a href="/pmc/articles/PMC5602878/bin/12885_2017_3616_MOESM6_ESM.pdf" data-ga-action="click_feat_suppl">12885_2017_3616_MOESM6_ESM.pdf</a><span style="color:gray"> (86K)</span></div><div class="small guid">GUID: 28168D87-75A8-4514-A507-70537AC3A1C7</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Additional file 7: Table S2: </strong>Proteins significantly regulated upon TRAP perturbation in any of the phosphoproteomics or proteomics analyses (TRAP3<sup>high</sup> vs ctrl, phospho and standard proteomics analyses; TRAP sh2 or sh3&#x000a0;+&#x000a0;4 vs scrambled shRNA, standard proteomics analysis). The column &#x0201c;Enriched GO term&#x0201d; specifies whether the protein belong to any of the GO terms that were found to be enriched in the list of regulated proteins. The column &#x0201c;Protein class&#x0201d; describes to which of the examined protein class a protein belongs to. Examined proteins classes include protein kinases, protein phosphatases, ubiquitin and UBL system enzymes and transcription factors. (XLSX 79 kb)</div><div><a href="/pmc/articles/PMC5602878/bin/12885_2017_3616_MOESM7_ESM.xlsx" data-ga-action="click_feat_suppl">12885_2017_3616_MOESM7_ESM.xlsx</a><span style="color:gray"> (80K)</span></div><div class="small guid">GUID: 4A4EF06A-111E-4DAF-9E2E-CAB8C72CCC54</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Additional file 8: Figure S5: </strong>Functional analysis after treatment with TGF&#x003b2;1 (10&#x000a0;&#x003bc;g/mL, A, B, <em>n</em>&#x000a0;=&#x000a0;5) and respective controls. Live cell imaging was performed over 30&#x000a0;h in serum-free medium containing blocking antibody or small molecule inhibitor and wound migration velocity (A) and migration curves are compared. Cell proliferation was assessed after 24&#x000a0;h treatment in complete medium (B). Statistical comparison was performed on biological replicates by ANOVA test. Groups are generally compared to their respective controls (ctrl, untreated) or indicated with brackets and significance is annotated with an asterisk (*). ns&#x000a0;=&#x000a0;non-significant. &#x0201c;n=&#x0201d; indicates the number of replicates. (PDF 952 kb)</div><div><a href="/pmc/articles/PMC5602878/bin/12885_2017_3616_MOESM8_ESM.pdf" data-ga-action="click_feat_suppl">12885_2017_3616_MOESM8_ESM.pdf</a><span style="color:gray"> (952K)</span></div><div class="small guid">GUID: 178F8A35-8092-47EA-9A56-3D7F08A379A8</div></div></dd></dl><dl data-length="470" class="box-data-avail whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-avl-stmnt" data-ga-action="click_feat_toggler" data-ga-label="Data Availability Statement" class="pmctoggle">Data Availability Statement</a></dt><dd id="data-avl-stmnt" style="display: none;"><p class="p p-first-last">The datasets generated and/or analyzed during the current study are available in the ProteomeXchange/ PRIDE database: &#x0201c;Proteomic and phosphoproteomics profiling of breast cancer cells with altered expression level of the protein phosphatase TRAP&#x0201d;, dataset identifier PXD006430 (<a href="https://www.ebi.ac.uk/pride/archive/login" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://www.ebi.ac.uk/pride/archive/login</a>). Other raw data generated and/or analyzed during the current study are available from the corresponding author on reasonable request.</p></dd></dl></div><div id="Abs1" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="Abs1title">Abstract</h2><!--article-meta--><div><div id="sec-a.v.b.n.a" class="sec sec-first"><h3 id="sec-a.v.b.n.atitle">Background</h3><p id="Par1" class="p p-first-last">Tartrate-resistant acid phosphatase (TRAP/<em>ACP5</em>), a metalloenzyme that is characteristic for its expression in activated osteoclasts and in macrophages, has recently gained considerable focus as a driver of metastasis and was associated with clinically relevant parameters of cancer progression and cancer aggressiveness.</p></div><div id="sec-a.v.b.n.b" class="sec"><h3 id="sec-a.v.b.n.btitle">Methods</h3><p id="Par2" class="p p-first-last">MDA-MB-231 breast cancer cells with different TRAP expression levels (overexpression and knockdown) were generated and characterized for protein expression and activity levels. Functional cell experiments, such as proliferation, migration and invasion assays were performed as well as global phosphoproteomic and proteomic analysis was conducted to connect molecular perturbations to the phenotypic changes.</p></div><div id="sec-a.v.b.n.c" class="sec"><h3 id="sec-a.v.b.n.ctitle">Results</h3><p id="Par3" class="p p-first-last">We identified an association between metastasis-related properties of TRAP-overexpressing MDA-MB-231 breast cancer cells and a TRAP-dependent regulation of Transforming growth factor (TGF&#x003b2;) pathway proteins and Cluster of differentiation 44 (CD44). Overexpression of TRAP increased anchorage-independent and anchorage-dependent cell growth and proliferation, induced a more elongated cellular morphology and promoted cell migration and invasion. Migration was increased in the presence of the extracellular matrix (ECM) proteins osteopontin and fibronectin and the basement membrane proteins collagen IV and laminin I. TRAP-induced properties were reverted upon shRNA-mediated knockdown of TRAP or treatment with the small molecule TRAP inhibitor 5-PNA. Global phosphoproteomics and proteomics analyses identified possible substrates of TRAP phosphatase activity or signaling intermediates and outlined a TRAP-dependent regulation of proteins involved in cell adhesion and ECM organization. Upregulation of TGF&#x003b2; isoform 2 (TGF&#x003b2;2), TGF&#x003b2; receptor type 1 (T&#x003b2;R1) and Mothers against decapentaplegic homolog 2 (SMAD2), as well as increased intracellular phosphorylation of CD44 were identified upon TRAP perturbation. Functional antibody-mediated blocking and chemical inhibition demonstrated that TRAP-dependent migration and proliferation is regulated via TGF&#x003b2;2/T&#x003b2;R, whereas proliferation beyond basal levels is regulated through CD44.</p></div><div id="sec-a.v.b.n.d" class="sec"><h3 id="sec-a.v.b.n.dtitle">Conclusion</h3><p id="Par4" class="p p-first-last">Altogether, TRAP promotes metastasis-related cell properties in MDA-MB-231 breast cancer cells via TGF&#x003b2;2/T&#x003b2;R and CD44, thereby identifying a potential signaling mechanism associated to TRAP action in breast cancer cells.</p></div><div id="sec-a.v.b.n.e" class="sec sec-last"><h3 id="sec-a.v.b.n.etitle">Electronic supplementary material</h3><p class="p p-first-last">The online version of this article doi:(10.1186/s12885-017-3616-7) contains supplementary material, which is available to authorized users.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text"><em>ACP5</em>, TRAP, 5-PNA, TGF&#x003b2;2, CD44, MDA-MB-231</span></div></div><div id="Sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec1title">Background</h2><p id="Par11" class="p p-first">Tartrate-resistant acid phosphatase (TRAP/<em>ACP5</em>) is a metalloenzyme of the category of acid phosphatases [<a href="#CR1" rid="CR1" class=" bibr popnode">1</a>] that is synthesized as a monomeric proenzyme (TRAP 5a, 35&#x000a0;kDa) [<a href="#CR2" rid="CR2" class=" bibr popnode">2</a>]. A disulfide linked heterodimer (TRAP 5b) with an N-terminal fragment of 20&#x02013;23&#x000a0;kDa joined to the 16 to 17&#x000a0;kDa C-terminal part originates from post-translational cleavage of the monomeric form, which significantly increases phosphatase activity [<a href="#CR3" rid="CR3" class=" bibr popnode">3</a>]. TRAP derived from different mammalian sources reveals almost identical homology at the amino acid sequence level and identical biochemical properties [<a href="#CR4" rid="CR4" class=" bibr popnode">4</a>&#x02013;<a href="#CR7" rid="CR7" class=" bibr popnode">7</a>]. During bone resorption, TRAP is secreted into the resorption lacuna of active osteoclasts, where it dephosphorylates the bone matrix protein osteopontin (OPN), thereby promoting osteoclast detachment and migration [<a href="#CR8" rid="CR8" class=" bibr popnode">8</a>]. Additionally, TRAP has been suggested to regulate OPN bioactivity in autoimmune conditions [<a href="#CR9" rid="CR9" class=" bibr popnode">9</a>&#x02013;<a href="#CR11" rid="CR11" class=" bibr popnode">11</a>]. The isoform TRAP 5b was proposed as a serum marker for bone metastases in various types of primary cancers [<a href="#CR12" rid="CR12" class=" bibr popnode">12</a>&#x02013;<a href="#CR16" rid="CR16" class=" bibr popnode">16</a>]. Interestingly, TRAP has also been detected in several cancer cells and tissues (breast, ovarian, cervical cancer and malignant melanoma) and its expression level correlates with the severity of the tumor [<a href="#CR17" rid="CR17" class=" bibr popnode">17</a>&#x02013;<a href="#CR19" rid="CR19" class=" bibr popnode">19</a>]. Moreover, high TRAP expression correlates with reduced tumor- and metastasis-free survival in malignant melanoma [<a href="#CR20" rid="CR20" class=" bibr popnode">20</a>], and with decreased overall survival and increased incidence of metastasis in hepatocellular cancer [<a href="#CR21" rid="CR21" class=" bibr popnode">21</a>]. In gastric cancer, elevated TRAP expression is an independent risk factor for peritoneal dissemination and is associated with shorter patient survival [<a href="#CR22" rid="CR22" class=" bibr popnode">22</a>]. In lung cancer, patients with high TRAP expression had a significantly lower overall survival than the patients with low TRAP expression [<a href="#CR23" rid="CR23" class=" bibr popnode">23</a>].</p><p id="Par12">Altogether, previous studies underscore the potential clinical relevance of TRAP to monitor cancer development and progression; nevertheless, underlying cellular and molecular processes remain unclear.</p><p id="Par13">TRAP was shown to interact intracellularly with the Transforming growth factor &#x003b2; (TGF&#x003b2;) receptor interacting protein-1 (TRIP-1), thereby activating TGF&#x003b2; receptor type II (T&#x003b2;R2) and osteoblast differentiation through the Mothers against decapentaplegic homolog 2/3 (SMAD2/3) pathway at sites of prior bone resorption [<a href="#CR24" rid="CR24" class=" bibr popnode">24</a>]. Furthermore, TRIP-1 knock-down abrogates osteoblast differentiation and proliferation [<a href="#CR25" rid="CR25" class=" bibr popnode">25</a>]. TRAP 5a interaction with TRIP-1 has also been demonstrated in mouse pre-adipocytes [<a href="#CR26" rid="CR26" class=" bibr popnode">26</a>].</p><p id="Par14">TGF&#x003b2; ligands exist in three highly homologous isoforms, TGF&#x003b2;1, TGF&#x003b2;2 and TGF&#x003b2;3 and are part of a large family of structurally related secreted cytokines [<a href="#CR27" rid="CR27" class=" bibr popnode">27</a>&#x02013;<a href="#CR29" rid="CR29" class=" bibr popnode">29</a>]. Upon ligand binding to the constitutively active serine/threonine kinase T&#x003b2;R2 [<a href="#CR30" rid="CR30" class=" bibr popnode">30</a>], the latter forms a hetero-oligomeric complex with the type I receptor (T&#x003b2;R1). T&#x003b2;R2 then trans-phosphorylates T&#x003b2;R1, ultimately leading to the transcription of various target genes via both SMAD- and non-SMAD mediated pathways (reviewed in [<a href="#CR29" rid="CR29" class=" bibr popnode">29</a>, <a href="#CR31" rid="CR31" class=" bibr popnode">31</a>&#x02013;<a href="#CR34" rid="CR34" class=" bibr popnode">34</a>]). TGF&#x003b2; acts as tumor repressor in early stages of tumorigenesis and as an oncogene in late stages [<a href="#CR28" rid="CR28" class=" bibr popnode">28</a>]. For instance, in breast cancer patients expression of TGF&#x003b2; was increased in tumor tissue [<a href="#CR35" rid="CR35" class=" bibr popnode">35</a>, <a href="#CR36" rid="CR36" class=" bibr popnode">36</a>] and was associated with disease progression [<a href="#CR36" rid="CR36" class=" bibr popnode">36</a>, <a href="#CR37" rid="CR37" class=" bibr popnode">37</a>]. TGF&#x003b2;2 has been proposed as a predictive marker for breast cancer, as high levels of TGF&#x003b2;2 correlate with advanced tumor stage and shortened survival [<a href="#CR38" rid="CR38" class=" bibr popnode">38</a>]. Additionally, TGF&#x003b2;2 was reported as a catalyzer of TGF&#x003b2; signaling through an autocrine loop [<a href="#CR39" rid="CR39" class=" bibr popnode">39</a>]. Finally, T&#x003b2;R1 contain a single cytoplasmic binding site for Cluster of differentiation 44 (CD44) [<a href="#CR40" rid="CR40" class=" bibr popnode">40</a>], suggesting a potential interaction between the TGF&#x003b2; pathway and CD44, a cancer-associated glycoprotein previously reported as an OPN receptor [<a href="#CR41" rid="CR41" class=" bibr popnode">41</a>]. Activated CD44 stimulates the serine/threonine kinase activity of T&#x003b2;R1, which in turns increases SMAD2/3 phosphorylation [<a href="#CR40" rid="CR40" class=" bibr popnode">40</a>].</p><p id="Par15" class="p p-last">Aim of this study was to delineate by proof-of-concept, how TRAP promotes cellular properties related to metastasis in breast cancer cells at advanced state. As there is only limited knowledge about the molecular perturbations and possible substrates of TRAP, global phosphoproteomic and proteomic analysis was applied to connect possible signaling mechanisms to the TRAP-dependent phenotypic changes.</p></div><div id="Sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec2title">Methods</h2><div id="Sec3" class="sec sec-first"><h3 id="Sec3title">Reagents</h3><p id="Par16" class="p p-first">
<strong>Matrix proteins:</strong> bovine milk OPN, previously purified by our group [<a href="#CR42" rid="CR42" class=" bibr popnode">42</a>, <a href="#CR43" rid="CR43" class=" bibr popnode">43</a>], murine Engelbrecht-holm-swarm Laminin-1 (Lam I, Sigma-Aldrich, #L2020), human plasma Fibronectin (FN, Life Technologies, #PHE0023), human recombinant natural Vitronectin (VN, Life Technologies, #PHE0011), Cultrex&#x000ae; Rat Collagen I, (Col I, Trevigen, Cat# 3440&#x02013;100-01), human placenta Collagen IV (Col IV, Merck Millipore, Cat# CC076) (10&#x000a0;&#x003bc;g/ml).</p><p id="Par17">
<strong>Antibodies:</strong> rabbit antibody serum against total TRAP (raised by immunization of New Zealand rabbits [<a href="#CR44" rid="CR44" class=" bibr popnode">44</a>], 1:1000, TRAP 5a: 37&#x000a0;kDa, TRAP 5b: 16 and 25&#x000a0;kDa), mouse anti-&#x003b2;-Actin (1:1000, 42&#x000a0;kDa; Cat# 8224, Abcam), rabbit anti-TGF&#x003b2;2 (Western blotting 1:1000, 48&#x000a0;kDa; ICC 1:200; Cat# 113670, Abcam), secondary donkey anti-mouse (Licor IRDye&#x000ae; 800CW, Cat# 925&#x02013;32,212; 1:15,000); donkey anti-rabbit (Licor IRDye&#x000ae; 680RD, Cat# 926&#x02013;68,073; 1:15,000); goat anti-rabbit (Licor IRDye&#x000ae; 680RD Cat# 926&#x02013;68,071; 1:15,000); secondary goat anti-rabbit Alexa 488 (1:100, Cat#A11008, Life Technologies).</p><p id="Par18" class="p p-last">
<strong>Recombinant protein, blocking antibodies and inhibitory compounds:</strong> rat monoclonal IgG2A Isotype Control (respective similar concentration, Novus Biologicals, MAB006, 54,447), rat monoclonal anti-CD44 (10&#x000a0;&#x003bc;g/mL, Novus Biologicals, Hermes-1, NBP2&#x02013;22530), rabbit polyclonal anti-TGF&#x003b2;2 (0,25&#x000a0;&#x003bc;g/mL, R&#x00026;D systems, AB-12-NA); TGF&#x003b2; receptor type I/type II kinases inhibitor LY2109761 (2&#x000a0;&#x003bc;M, Santa Cruz; CAS 700874&#x02013;71-1, PubChem CID <a href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=11655119" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">11655119</a>), Human recombinant TGF&#x003b2;1 (10&#x000a0;ng/mL, R&#x00026;D systems, 240-B), TRAP inhibitor 5-PNA (200&#x000a0;&#x003bc;M, 5-phenylnicotinic acid, Maybridge code CC24201, Sigma-Aldrich code CDS013984; PubChem CID 346160, previously characterized by our group [<a href="#CR45" rid="CR45" class=" bibr popnode">45</a>]).</p></div><div id="Sec4" class="sec"><h3 id="Sec4title">Cell transfection and culture</h3><p id="Par19" class="p p-first">MDA-MB-231 breast cancer cell line was obtained from American Type Culture Collection (Manassas, U.S., ATCC&#x000ae; Number: <a href="https://www.lgcstandards-atcc.org/en/Products/All/HTB-26.aspx" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">HTB-26&#x02122;</a>). MDA-MB-231 were previously stably transfected with the eukaryotic expression vector pcI-neo containing the full size rat TRAP [<a href="#CR46" rid="CR46" class=" bibr popnode">46</a>] and different subpopulations maintained in complete medium (RPMI 1640, 10% fetal bovine serum, 0.1&#x000a0;mg/mL Gentamicin) (Life technologies, <a href="https://www.google.se/search?sa=X&#x00026;rlz=1C1BLWB_enSE567SE567&#x00026;es_sm=93&#x00026;biw=1706&#x00026;bih=1230&#x00026;q=carlsbad+california&#x00026;stick=H4sIAAAAAAAAAGOovnz8BQMDgwsHnxCXfq6-gUlVRUp8rhIHiF1kUp6npZWdbKWfX5SemJdZlViSmZ-HwrHKSE1MKSxNLCpJLSrWVFixcmJyFKMkn9zH7fzvj79bOC8JAP2RSVthAAAA&#x00026;ei=7rn9VNOYNor9ygO9-oCYAw&#x00026;ved=0CJYBEJsTKAEwEQ" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Carlsbad</a>, <a href="https://www.google.se/search?sa=X&#x00026;rlz=1C1BLWB_enSE567SE567&#x00026;es_sm=93&#x00026;biw=1706&#x00026;bih=1230&#x00026;q=california&#x00026;stick=H4sIAAAAAAAAAGOovnz8BQMDgwsHnxCXfq6-gUlVRUp8rhIHiG2YZ16opZWdbKWfX5SemJdZlViSmZ-HwrHKSE1MKSxNLCpJLSo-9GuRaiSL_N-PXgdL-Hla7v5v3dwJAFQmsKhhAAAA&#x00026;ei=7rn9VNOYNor9ygO9-oCYAw&#x00026;ved=0CJcBEJsTKAIwEQ" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">CA</a>, <a href="https://www.google.se/search?sa=X&#x00026;rlz=1C1BLWB_enSE567SE567&#x00026;es_sm=93&#x00026;biw=1706&#x00026;bih=1230&#x00026;q=united+states+of+america&#x00026;stick=H4sIAAAAAAAAAGOovnz8BQMDgysHnxCXfq6-gUlVRUp8rhIniG2ZbF5uoKWVnWyln1-UnpiXWZVYkpmfh8KxykhNTCksTSwqSS0qli6eIpt2yHk_92amGXIz-NQu393_HABLwXLoYgAAAA&#x00026;ei=7rn9VNOYNor9ygO9-oCYAw&#x00026;ved=0CJgBEJsTKAMwEQ" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">U.S.</a>) at 37&#x000a0;&#x000b0;C in a 5% CO<sub>2</sub> humidified atmosphere. Cells were continuously tested for contamination with the MycoAlert&#x02122; mycoplasma detection kit (Lonza, Cat# LT07).</p><p id="Par20" class="p p-last">Knockdown of rat TRAP was achieved by the use of different custom cloned MISSION shRNA constructs within the lentivirus plasmid vector pLKO.1-puro containing ampicillin and puromycin antibiotic resistance genes (Sigma Aldrich, St. Louis, MO, U.S.). Transfections were done with Escort II transfection reagent according to the manufacturer&#x02019;s instructions. 1&#x000a0;&#x003bc;g of purified DNA was complexed with 5&#x000a0;&#x003bc;l transfection reagent and applied to the cells for 24&#x000a0;h. Cells transfected with plasmids encoding antibiotic resistance were selected by culture of complete medium supplemented with 1&#x000a0;&#x003bc;g/mL puromycin (Sigma Aldrich, St. Louis, MO, U.S.). TRAP gene expression in the cells bearing a knockdown was quantified according to a detailed description in the Additional&#x000a0;file&#x000a0;<a href="#MOESM1" rid="MOESM1" class=" media">1</a>: Material and Methods.</p></div><div id="Sec5" class="sec"><h3 id="Sec5title">Tartrate-resistant acid phosphatase activity assay</h3><p id="Par21" class="p p-first-last">Cell lysates and conditioned media were prepared according to a detailed description in the Additional&#x000a0;file&#x000a0;<a href="#MOESM1" rid="MOESM1" class=" media">1</a>: Material and Methods. TRAP activity in cell lysate and medium was measured under optimal enzyme conditions using 10&#x000a0;mM p-nitrophenyl-phosphate as a synthetic substrate (Sigma Aldrich) as previously described [<a href="#CR45" rid="CR45" class=" bibr popnode">45</a>]. Enzymatic activity was calculated in enzyme Units according to Lambert-Beer and normalized to total protein concentration for lysate or per 10<sup>6</sup> cells per 24&#x000a0;h for medium.</p></div><div id="Sec6" class="sec"><h3 id="Sec6title">Immunoblotting</h3><p id="Par22" class="p p-first-last">Cell lysates and conditioned media were prepared according to a detailed description in the Additional&#x000a0;file&#x000a0;<a href="#MOESM1" rid="MOESM1" class=" media">1</a>: Material and Methods. 25&#x02013;50&#x000a0;&#x003bc;g of total protein and normalized volumes of corresponding medium were subjected to SDS-PAGE (Mini-PROTEAN&#x000ae;TGX&#x02122; precast gel, Biorad) and transferred to PVDF membrane (Trans-Blot turbo mini PVDF packs, Biorad) according to the manufacturer&#x02019;s instructions. Unspecific binding was blocked by 3% bovine serum albumin (BSA) in PBS for 1&#x000a0;h at room temperature (R.T.) and protein bands detected by subsequent incubation with respective primary antibodies in each 3% BSA overnight (o.n.) at 4&#x000a0;&#x000b0;C and fluorescently labelled secondary antibodies for 1&#x000a0;h at R.T.. The membranes were washed with TBST (20&#x000a0;mM Tris- HCl pH&#x000a0;7.5, 500&#x000a0;mM NaCl, 0.05% Tween-20) after antibody incubations and visualized in the Licor Odyssey Fc Imager and quantified by densitometry with the Licor Image Studio software 3.1.4 (Licor Biosciences, <a href="http://en.wikipedia.org/wiki/Lincoln,_Nebraska" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Lincoln, NE, U.S.</a>) upon normalization to &#x003b2;-Actin expression for lysates.</p></div><div id="Sec7" class="sec"><h3 id="Sec7title">Anchorage-independent growth</h3><p id="Par23" class="p p-first-last">6-well plates were precoated with a bottom layer of 0.8% low melting Agarose solution (Sigma Aldrich, A9414) prepared in complete medium and gel formation allowed for at least 1&#x000a0;h at R.T.. After gelling, 10,000 cells were incorporated in a 0.35% Agarose solution and overlaid on the previous high Agarose-containing lower layer. During regular feeding, cells were allowed to form colonies for 3&#x000a0;weeks and agarose gels fixed in formaldehyde (Solvecco). Colonies were stained in 0.01% Crystal violet solution in formaldehyde o.n. and 1X images taken. Images were changed to binaries and threshold adjusted on all images using Image J 1.48 software. Colony number and sizes were quantified by the &#x0201c;count particles&#x0201d; function with a threshold of 50 pixels as minimum detection limit and inclusion of colonies with circularity from 0 to 1.</p></div><div id="Sec8" class="sec"><h3 id="Sec8title">Cell growth assay</h3><p id="Par24" class="p p-first-last">Fifty thousand cells were seeded in 48-well plates in complete medium and let adhere and grow for 24&#x000a0;h or 48&#x000a0;h. The cells were washed with PBS, fixed in formaldehyde and stained for 5&#x000a0;min in 0.1% Toluidine blue. Excess color was washed away with PBS and color dissolved for 5&#x000a0;min in 50% EtOH/50&#x000a0;mM HCl. Absorbance was measured at 630&#x000a0;nm in a <a href="http://www.biotek.com/products/microplate_detection/powerwave_microplate_spectrophotometer.html" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">PowerWave HT Microplate Spectrophotometer</a> (Biotek, Winooski, VT, U.S.).</p></div><div id="Sec9" class="sec"><h3 id="Sec9title">Cell proliferation</h3><p id="Par25" class="p p-first-last">Fifty thousand cells were seeded into glass 8-well chambers (Labtek II, 154534) and let adhere o.n.. After a PBS wash, medium was changed, respectively, conditionally containing blocking antibodies or inhibiting compounds or deficient in serum and maintained for another 24&#x000a0;h. Following, the cells were pulsated with 10&#x000a0;&#x003bc;M EdU for 1&#x000a0;h and subsequently fixed in 4% formaldehyde for 10&#x000a0;min. Fluorescent staining was performed according to the manufacturer&#x02019;s protocol with the Click-iT&#x000ae; Plus EdU Alexa Fluor 488 Imaging Kit (Cat# <a id="__tag_1139357135" class="tag_hotlink" href="/nuccore/C10637" ref="/nuccore/C10637"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"C10637","term_id":"1535708","term_text":"C10637"}}</span>C10637</a>, Invitrogen, Life Technologies Europe BV, Stockholm, Sweden). Confocal images were acquired in the Nikon A1+ <a href="http://www.nikoninstruments.com/Information-Center/Confocal" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">confocal</a> laser microscope system and image batch analysis performed in the Nis Elements Advance research imaging software 4.1.0 (Nikon). For automated cell counting, thresholding was adapted to experimental controls and nuclei with circularity greater than 0.1 and size (diameter) greater than 5&#x000a0;&#x003bc;m taken into account.</p></div><div id="Sec10" class="sec"><h3 id="Sec10title">Cell morphology</h3><p id="Par26" class="p p-first-last">Bright field phase contrast images of cells cultured in complete medium were taken at equal confluence and at different time points in a Nikon Eclipse TE300 Inverted microscope equipped with a DS-Fi1 digital microscope camera and a DS-U2 camera control unit (Nikon, <a href="https://www.google.se/search?rlz=1C1BLWB_enSE567SE567&#x00026;espv=2&#x00026;biw=1706&#x00026;bih=1230&#x00026;q=tokyo&#x00026;stick=H4sIAAAAAAAAAGOovnz8BQMDgx0HnxCnfq6-gXFBblq5EgeIaZ6Slq2lmp1spZ9flJ6Yl1mVWJKZn4fCsUrLL81LSU1JO83tMOmmWOc2p02vFtzjv9Gmo-0IAAUNOo9bAAAA&#x00026;sa=X&#x00026;ei=TIT4VLmJFIfQygPji4HwCQ&#x00026;ved=0CJcBEJsTKAEwEg" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Tokyo, Japan</a>). Ratios of cell length to cell width were acquired for all cells using the Straight line tool in Image J 1.48 program. A minimum of 200 cells was randomly measured per time point and ratio medians calculated.</p></div><div id="Sec11" class="sec"><h3 id="Sec11title">Live cell wound migration</h3><p id="Par27" class="p p-first-last">Wound migration experiments were performed and analyzed as previously described [<a href="#CR45" rid="CR45" class=" bibr popnode">45</a>]. Medium was respectively enriched with blocking antibodies, chemical inhibitors or compounds.</p></div><div id="Sec12" class="sec"><h3 id="Sec12title">Transwell migration assay</h3><p id="Par28" class="p p-first-last">Transwell assays membranes (Corning Incorporated Costar-Transwell CLS3422-48EA) were precoated on the lower side of the insert with 10&#x000a0;&#x003bc;g/mL of matrix proteins in PBS under humidified atmosphere at 4&#x000a0;&#x000b0;C for 24&#x000a0;h. Following, 200,000 cells were seeded into the upper chamber of the Transwell and both wells filled with serum-free medium. Migration was allowed for two different time periods during linear increase (OPN: 8&#x000a0;h, 22&#x000a0;h; FN: 2&#x000a0;h, 4&#x000a0;h; VN: 6&#x000a0;h, 8&#x000a0;h; Col I: 2&#x000a0;h, 4&#x000a0;h; Col IV: 4&#x000a0;h, 8&#x000a0;h; Lam I: 2&#x000a0;h, 4&#x000a0;h). Cells that had migrated on the lower membrane surface were fixed in 4% formaldehyde and stained in 0.1% Crystal violet solution (200&#x000a0;mM Borat, pH&#x000a0;9) for 10&#x000a0;min. Cells left on the upper side of the Transwell membrane were removed and excess color washed away with water. Images were taken at 20 X magnification. Color was dissolved in 10% acetic acid for 5&#x000a0;min and read at 600&#x000a0;nm.</p></div><div id="Sec13" class="sec"><h3 id="Sec13title">Transwell invasion assay</h3><p id="Par29" class="p p-first-last">CytoSelect&#x02122; 96-Well Cell Invasion Assays (Cellbiolabs, Cat#CBA-112, San Diego, CA, U.S.;) were performed according to the manufacturer&#x02019;s protocol as previously described [<a href="#CR45" rid="CR45" class=" bibr popnode">45</a>].</p></div><div id="Sec14" class="sec"><h3 id="Sec14title">Immunocytochemistry</h3><p id="Par30" class="p p-first-last">Twenty thousand cells were allowed to grow for 48&#x000a0;h in complete medium in an 8-well chambered slide (Labtek II, 154534). Cells were washed in serum-free medium, fixed with 4% formaldehyde (Solvecco) and washed in TBST (25&#x000a0;mM Tris pH&#x000a0;7.4, 150&#x000a0;mM NaCl, 0.1% Tween 20) followed by permeabilization in 0.1% Triton X-100 (Sigma-Aldrich) for each 10&#x000a0;mins at R.T.. Unspecific binding was blocked in 1% BSA/TBST (Sigma-Aldrich) at R.T. for 1&#x000a0;h followed by incubation with primary and secondary antibodies for each 1&#x000a0;h at R.T.. Cells were after antibody incubations washed twice with TBST and finally stained with Hoechst (1:7500 dilutions, Life technologies) for 3 mins. The cells were washed, mounted in fluorescent mounting media (DAKO) and imaged using a Nikon A1+ <a href="http://www.nikoninstruments.com/Information-Center/Confocal" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">confocal</a> laser microscope system equipped with Nis Elements Advance research imaging software 4.3.0 (Nikon, Sweden, Stockholm) at 60 X. For quantification fluorescent signal intensity in 100&#x02013;400 cells per experiment was measured with respect to a threshold set on experimental controls.</p></div><div id="Sec15" class="sec"><h3 id="Sec15title">Peptide level high-resolution isoelectric focusing (HiRIEF)</h3><p id="Par31" class="p p-first">SILAC labeled peptide samples were prepared for quantitative phosphoproteomics and proteomics analysis of control cells and TRAP3<sup>high</sup> cells, while TMT labeled peptide samples were prepared for scrambled and knockdown cells (sh2 and sh3&#x000a0;+&#x000a0;4) according to a detailed description in the Additional&#x000a0;file&#x000a0;<a href="#MOESM1" rid="MOESM1" class=" media">1</a>: Material and Methods.</p><p id="Par32" class="p p-last">HiRIEF was performed as described previously for analysis of both SILAC and TMT labeled samples [<a href="#CR47" rid="CR47" class=" bibr popnode">47</a>]. Immobilized pH gradient (IPG) gel strips (GE Healthcare Bio-Sciences AB, Uppsala, Sweden) with linear pH ranges of 2.5&#x02013;3.7 (&#x0201c;ultra-acidic&#x0201d; range) and of 3&#x02013;10 (&#x0201c;wide range&#x0201d;) were employed for standard phosphoproteomics and for proteomics analyses, respectively. Strips were divided into 72 fractions (fraction numbering proceeds from the acidic end towards the basic end of the strips), and extracted to V-bottom 96-well plates with a liquid handling robot (GE Healthcare prototype modified from Gilson liquid handler 215). Plates were lyophilized in a Speedvac prior to liquid chromatography-mass spectrometry (LC-MS) analysis.</p></div><div id="Sec16" class="sec"><h3 id="Sec16title">LC-MS data statistical analyses</h3><p id="Par33" class="p p-first">The LC-MS proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD006430. (<a href="https://www.ebi.ac.uk/pride/archive/login" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://www.ebi.ac.uk/pride/archive/login</a>). Details regarding the LC-MS analysis and the calculations of protein and phospho-site ratios are described in Additional&#x000a0;file&#x000a0;<a href="#MOESM1" rid="MOESM1" class=" media">1</a>: Material and Methods.</p><p id="Par34" class="p p-last">To define significantly regulated events in both SILAC-based or TMT-based quantitative analysis, a median absolute deviation (MAD) value for all the ratios in each experimental condition was calculated as the median absolute value of the differences between each individual log<sub>2</sub>(ratio) and the median log<sub>2</sub>(ratio). All log<sub>2</sub> transformed ratios were median absolute deviation (MAD) scaled by calculating robust z-scores (MADs away from the median), as described before [<a href="#CR48" rid="CR48" class=" bibr popnode">48</a>, <a href="#CR49" rid="CR49" class=" bibr popnode">49</a>], to correct for their skewed distributions. Significantly regulated events were those with robust z-scores of at least &#x02212;/+ 2.5 and &#x02212;/+ 3 in both replicates for SILAC-based phosphoproteomics and standard proteomics analysis respectively. For TMT-based standard proteomics analysis, significantly regulated events were those with average robust z-scores of at least &#x02212;/+ 3 and t-test <em>p</em>-value &#x0003c;0.01 for both sh2 and sh3&#x000a0;+&#x000a0;4 samples.</p></div><div id="Sec17" class="sec"><h3 id="Sec17title">Bioinformatics analyses</h3><p id="Par35" class="p p-first">Plots were generated using RStudio. Gene assignment to different classes was based on information retrieved from publicly available databases for protein kinases [<a href="#CR50" rid="CR50" class=" bibr popnode">50</a>], protein phosphatases [<a href="#CR51" rid="CR51" class=" bibr popnode">51</a>], transcription factors [<a href="#CR52" rid="CR52" class=" bibr popnode">52</a>&#x02013;<a href="#CR54" rid="CR54" class=" bibr popnode">54</a>] and enzymes of the ubiquitin and ubiquitin-like (UBL) conjugation systems [<a href="#CR55" rid="CR55" class=" bibr popnode">55</a>]. The list of human phosphorylation sites with a previously reported function was obtained from the PhosphositePlus database, released 2017&#x02013;02-16 [<a href="#CR56" rid="CR56" class=" bibr popnode">56</a>]. Gene ontology (GO) enrichment analysis was performed with the web service GOrilla by selecting the &#x0201c;Two unranked lists of genes&#x0201d; option and setting a <em>p</em>-value threshold of 10<sup>&#x02212;3</sup>. The target set included all the genes that were significantly regulated in either of the proteomics and phosphoproteomics analyses (842 genes), while the background set was the list of all the identified genes (9570 genes).</p><p id="Par36" class="p p-last">Network analysis of the phosphorylated proteins was performed using the Cytoscape software platform. Significantly regulated genes from the GO analysis belonging to biological adhesion or ECM organization processes were employed to generate the network. Direct interactions between those genes were extracted from the STRING database (version 10.0, 2016&#x02013;04-16) [<a href="#CR57" rid="CR57" class=" bibr popnode">57</a>] and visualized with Cytoscape.</p></div><div id="Sec18" class="sec sec-last"><h3 id="Sec18title">Statistical analyses</h3><p id="Par37" class="p p-first">Results visualized in columnar graphs were expressed as mean values &#x000b1; standard deviation. Boxplots display the 25th and 75th percentile with medians as vertical line. Whiskers represent the minimum and maximum. Analysis and statistical comparison of the mean of at least three biological replicates was compared with GraphPad Prism 6 Software and each experiment based on one to five technical replicates. The respective amount of biological experiments was denoted more specifically in each figure legend. If not denoted specifically, TRAP-overexpressing cells were compared to control cells and TRAP knockdown cells compared to scrambled cells, respectively. In case of normal distribution, statistics was done by parametric two sample t-test (2 groups) or ANOVA test (&#x0003e; 2 groups). Otherwise, non-parametric Mann- Whitney test (2 groups) or Kruskal- Wallis one- way ANOVA on ranks (&#x0003e; 2 groups) was applied. A <em>p</em>-value &#x0003c;0.05 was considered significant (*); values <em>p</em>&#x02009;&#x0003c;&#x02009;0.01 (**), values <em>p</em>&#x02009;&#x0003c;&#x02009;0.001 (***), values <em>p</em>&#x02009;&#x0003c;&#x02009;0.0001 (****) were marked in the graphs, respectively.</p><p id="Par38" class="p p-last">See Additional&#x000a0;file&#x000a0;<a href="#MOESM1" rid="MOESM1" class=" media">1</a>: Material and Methods for description of gene expression analysis, cell lysis, SILAC labeling, protein extraction for mass spectrometric analyses, protein digestion, Tandem Mass Tag labeling, liquid chromatography tandem mass spectrometric analyses and proteomics database search, protein and phospho-peptide ratios calculation.</p></div></div><div id="Sec19" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec19title">Results</h2><div id="Sec20" class="sec sec-first"><h3 id="Sec20title">Generation and characterization of TRAP-overexpressing and TRAP knockdown MDA-MB-231 cells</h3><p id="Par39" class="p p-first">MDA-MB-231 cells, an invasive breast cancer cell line that has previously not been tested with regard to the role of TRAP was employed to test whether TRAP overexpression could further enhance invasive capabilities of these cells. As this cell line expresses low levels of TRAP, processing within the different cellular compartments, secretion, as well as signaling of TRAP in the overexpression system should be similar to the parental one. Four clonal populations of cells stably transfected with a full-length rat TRAP and a control cell population transfected with a mock insert (control) [<a href="#CR46" rid="CR46" class=" bibr popnode">46</a>], were characterized by comparing TRAP protein expression level and enzymatic activity in cell lysates and media (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1a-c</span></a>). As previously reported, in TRAP-overexpressing cells [<a href="#CR46" rid="CR46" class=" bibr popnode">46</a>] both isoforms TRAP 5a and TRAP 5b are present in cell lysates, whereas only the monomeric isoform 5a is present in the media (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1a</span></a>). TRAP-overexpressing cell populations possess intermediate (TRAP1<sup>low</sup> and TRAP2<sup>low</sup>) and high (TRAP3<sup>high</sup> and TRAP4<sup>high</sup>) TRAP protein levels and enzymatic activity in lysate and medium as compared to control cells (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1b, c</span></a>).
</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig1" co-legend-rid="lgnd_Fig1"><a href="/pmc/articles/PMC5602878/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140249778667952"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12885_2017_3616_Fig1_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12885_2017_3616_Fig1_HTML.jpg" src="/pmc/articles/PMC5602878/bin/12885_2017_3616_Fig1_HTML.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140249778667952"><a target="object" rel="noopener" href="/pmc/articles/PMC5602878/figure/Fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig1"><div><a class="figpopup" href="/pmc/articles/PMC5602878/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1">Fig. 1</a></div><!--caption a7--><div class="caption"><p>Generation and characterization of TRAP-overexpressing and TRAP knockdown MDA-MB-231 breast cancer cells. TRAP protein expression and enzymatic activity in MDA-MB-231 breast cancer cells overexpressing TRAP (TRAP1<sup>low</sup>, TRAP2<sup>low</sup>, TRAP3<sup>high</sup>, TRAP4<sup>high</sup>) compared to the mock-transfected control (ctrl) (<strong>a</strong>-<strong>c</strong>) and in TRAP knockdown cells (sh2 and sh3&#x000a0;+&#x000a0;4) compared to the scrambled control (scr) (<strong>d</strong>-<strong>g</strong>). TRAP knockdown was established by sh-hairpin technology in the TRAP3<sup>high</sup> clone and initially tested by TRAP mRNA quantification (<strong>d</strong>, <em>n</em>&#x000a0;=&#x000a0;3). One representative Western blot of TRAP staining of lysate and medium (monomeric TRAP 5a: 37&#x000a0;kDa, cleaved TRAP 5b: 16&#x000a0;kDa and 25&#x000a0;kDa) together with the normalization control &#x003b2;-Actin (42&#x000a0;kDa, only in lysate) is shown (<strong>a</strong>, <strong>e</strong>). Measurements in media are normalized to cell number and time in culture. Differential TRAP protein expression of the replicate means of biological replicates was quantified by densitometry (<strong>b</strong>, <em>n</em>&#x000a0;=&#x000a0;3; <strong>f</strong>, <em>n</em>&#x000a0;=&#x000a0;3). TRAP enzymatic activity, is normalized to total protein expression for lysates or number of cells and time in culture for medium (<strong>c</strong>, <em>n</em>&#x000a0;=&#x000a0;7; <strong>g</strong>, <em>n</em>&#x000a0;=&#x000a0;6). Statistical comparison was performed on biological replicates by Kruskal-Wallis test (Fig.&#x000a0;1<strong>b</strong>) or ANOVA test (Fig.&#x000a0;1<strong>c</strong>, <strong>d</strong>, <strong>f</strong>, <strong>g</strong>). Groups are generally compared to their respective controls (ctrl or scr) and significance is annotated with an asterisk (*). Specifically, the comparison of TRAP protein in medium between the high and low expressing cells TRAP<sup>low</sup> and TRAP4<sup>high</sup> is annotated with a hash (#). &#x0201c;n=&#x0201d; indicates the number of replicates</p></div></div></div><p id="Par40" class="p p-last">Additionally, TRAP3<sup>high</sup> cells were transfected with two different shRNA sequences targeting rat TRAP (sh2 and sh3&#x000a0;+&#x000a0;4) to generate TRAP knockdown cells. TRAP3<sup>high</sup> cells transfected with a scrambled shRNA sequence (scr) were used as control (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1d-g</span></a>). TRAP mRNA (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1d</span></a>) and protein expression (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1e, f</span></a>) were decreased by around 80% in TRAP knockdown cell lysates and media. TRAP enzymatic activity was decreased in both scrambled cells and TRAP knockdown cells compared to TRAP3<sup>high</sup> cells, however significantly lower in TRAP knockdown cells compared to scrambled cells (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1g</span></a>).</p></div><div id="Sec21" class="sec"><h3 id="Sec21title">Overexpression of TRAP increases cell growth and proliferation</h3><p id="Par41" class="p p-first-last">Anchorage-independent growth of TRAP3<sup>high</sup> cells was assayed by their ability to form colonies in soft agar (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span>2a</span></a>, one representative well per condition). Numbers of colonies were increased by 58% in TRAP3<sup>high</sup> cells compared to control cells (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span>2b</span></a>) and significantly larger than the ones formed by control cells (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span>2c</span></a>). Anchorage-dependent growth of TRAP3<sup>high</sup> and TRAP4<sup>high</sup> cells compared to control cells were increased by 44% and 50%, respectively, after 48&#x000a0;h of culture in serum-supplemented medium (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span>2d</span></a>). Proliferation, determined by the incorporation of the thymidine analogue EdU during S-phase, was increased from 31% in the control cells to 37%&#x02013;43% in the TRAP-overexpressing cells (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span>2e</span></a>). Accordingly, TRAP knockdown cells (sh3&#x000a0;+&#x000a0;4) displayed significantly lower proliferation than scrambled cells (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span>2f</span></a>). Additionally, inhibition of TRAP by the small molecule inhibitor 5-PNA normalized proliferation of the TRAP3<sup>high</sup> cells down to the level of the control cells, without affecting proliferation of the control cells (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span>2g</span></a>). Interestingly, TRAP3<sup>high</sup> cells also displayed an increased capacity to proliferate in serum-free medium after 48&#x000a0;h (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span>2h</span></a>), where around 9.5% of the TRAP3<sup>high</sup> cells remained cycling compared to 7% of the control cells.
</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig2" co-legend-rid="lgnd_Fig2"><a href="/pmc/articles/PMC5602878/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140249784798368"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12885_2017_3616_Fig2_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12885_2017_3616_Fig2_HTML.jpg" src="/pmc/articles/PMC5602878/bin/12885_2017_3616_Fig2_HTML.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140249784798368"><a target="object" rel="noopener" href="/pmc/articles/PMC5602878/figure/Fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig2"><div><a class="figpopup" href="/pmc/articles/PMC5602878/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2">Fig. 2</a></div><!--caption a7--><div class="caption"><p>TRAP increases growth and proliferation. Assessment of the impact of TRAP on anchorage-independent growth of TRAP-overexpressing TRAP3<sup>high</sup> cells (<strong>a</strong>-<strong>c</strong>, <em>n</em>&#x000a0;=&#x000a0;4). One representative well with colonies is shown in (<strong>a</strong>). After 3&#x000a0;weeks of culture colony number (<strong>b</strong>) and colony size (<strong>c</strong>) were measured. Anchorage-dependent growth of TRAP-overexpressing clone TRAP3<sup>high</sup> is assessed by spectral quantification of adhered cells cultured for 24&#x000a0;h and 48&#x000a0;h in complete medium (<strong>d</strong>, <em>n</em>&#x000a0;=&#x000a0;3). Measurement of proliferation is quantified based on the incorporation of EdU in the DNA during S-phase, immunocytochemistry and subsequent image analysis (<strong>e</strong>-<strong>h</strong>). Assessment of proliferation in TRAP-overexpressing (<strong>e</strong>, <em>n</em>&#x000a0;=&#x000a0;6&#x02013;14) and in the TRAP knockdown cells (<strong>f</strong>, <em>n</em>&#x000a0;=&#x000a0;3&#x02013;5) after 24&#x000a0;h culture in complete medium. Proliferation is also quantified in control cells (ctrl) and in TRAP-overexpressing TRAP3<sup>high</sup> cells after treatment with the small molecule TRAP inhibitor 5-PNA (200&#x000a0;&#x003bc;M) for 24&#x000a0;h (<strong>g</strong>, <em>n</em>&#x000a0;=&#x000a0;4) and after starvation for 24&#x000a0;h and 48&#x000a0;h (<strong>h</strong>, <em>n</em>&#x000a0;=&#x000a0;3). Statistical comparison was performed on biological replicates by t-test (Fig.&#x000a0;2<strong>b</strong>, <strong>f</strong>), Mann-Whitney test (Fig.&#x000a0;2
<strong>c</strong>) or ANOVA test (Fig.&#x000a0;2<strong>d</strong>, <strong>e</strong>, <strong>g</strong>, <strong>h</strong>). Groups are generally compared to their respective controls (ctrl or scr, DMSO treated) or indicated with brackets and significance is annotated with an asterisk (*). ns&#x000a0;=&#x000a0;non-significant. &#x0201c;n=&#x0201d; indicates the number of replicates</p></div></div></div></div><div id="Sec22" class="sec"><h3 id="Sec22title">TRAP enhances an elongated morphology and metastasis-related hallmarks</h3><p id="Par42" class="p p-first-last">TRAP affects cellular morphology as cells with increasing TRAP protein levels showed increasingly elongated phenotypes. Cellular length-to-width ratios were increased in the TRAP-overexpressing (TRAP1<sup>low</sup>, TRAP3<sup>high</sup>, TRAP4<sup>high</sup>) cells compared to control cells. Additionally, TRAP3<sup>high</sup> cells were more elongated than the TRAP1<sup>low</sup> cells (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span>3a</span></a>). This morphological phenotype was reverted upon TRAP downregulation, as shown by decreased length-to-width ratios in sh2 and sh3&#x000a0;+&#x000a0;4 cells compared to scrambled cells (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span>3b</span></a>). Furthermore, transwell migration was higher in TRAP3<sup>high</sup> cells than in control cells when the wells were coated with fibronectin (1.4-fold), collagen IV (1.6-fold) and laminin I (1.4-fold) (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span>3c</span></a>). Interestingly, a very prominent increase in transwell migration was observed in the presence of the phosphorylated extracellular matrix (ECM) protein osteopontin (OPN) (2.6-fold), a well-known substrate for TRAP [<a href="#CR10" rid="CR10" class=" bibr popnode">10</a>]. No difference in transwell migration was detected in the presence of vitronectin or collagen I. Furthermore, wound migration was assessed by live cell imaging over 30&#x000a0;h. TRAP<sup>high</sup> cells but not TRAP<sup>low</sup> cells displayed significantly increased migration velocity compared to the control cells; additionally migration velocity was significantly increased in TRAP3<sup>high</sup> cells compared to TRAP1<sup>low</sup> cells, indicating a level-dependent regulation of migration by TRAP (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span>3d</span></a>). Accordingly, migration velocity was decreased in sh2 and sh3&#x000a0;+&#x000a0;4 cells compared to scrambled cells (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span>3e</span></a>). Finally, TRAP also promoted transwell invasion through a basement membrane layer, as indicated by a 2.3&#x02013;3.3-fold increase in invasion in TRAP-overexpressing cells as compared to control cells (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span>3f</span></a>). Importantly, treatment with the TRAP inhibitor 5-PNA was recently shown to revert TRAP-dependent promotion of cell wound migration and transwell invasion [<a href="#CR45" rid="CR45" class=" bibr popnode">45</a>].
</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig3" co-legend-rid="lgnd_Fig3"><a href="/pmc/articles/PMC5602878/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140249775248128"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12885_2017_3616_Fig3_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12885_2017_3616_Fig3_HTML.jpg" src="/pmc/articles/PMC5602878/bin/12885_2017_3616_Fig3_HTML.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140249775248128"><a target="object" rel="noopener" href="/pmc/articles/PMC5602878/figure/Fig3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig3"><div><a class="figpopup" href="/pmc/articles/PMC5602878/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3">Fig. 3</a></div><!--caption a7--><div class="caption"><p>TRAP promotes an elongated morphology, migration and invasion. Impact of TRAP expression on functional features associated with cancer progression. Morphological analysis was performed on TRAP-overexpressing cells (<strong>a</strong>, <em>n</em>&#x000a0;=&#x000a0;9) and TRAP knockdown cells (<strong>b</strong>, <em>n</em>&#x000a0;=&#x000a0;4) and respective controls (ctrl or scr; &#x0003e;200 cells per condition) by measurement of length-to-width ratios in ImageJ program. Transwell migration derived from differences at two time points was assessed on inserts precoated with 10&#x000a0;&#x003bc;g/mL of the matrix and basement membrane proteins osteopontin (OPN, <em>n</em>&#x000a0;=&#x000a0;9), fibronectin (FN, <em>n</em>&#x000a0;=&#x000a0;9), collagen type I (Col I, <em>n</em>&#x000a0;=&#x000a0;10), collagen type IV (Col IV, <em>n</em>&#x000a0;=&#x000a0;10), vitronectin (VN, <em>n</em>&#x000a0;=&#x000a0;5), and laminin type I (Lam I, <em>n</em>&#x000a0;=&#x000a0;5) in serum-free medium (<strong>c</strong>). Wound migration experiments were performed by live cell imaging over 30&#x000a0;h of TRAP-overexpressing cells (<strong>d</strong>, <em>n</em>&#x000a0;=&#x000a0;3&#x02013;6) and TRAP knockdown cells (<strong>e</strong>, <em>n</em>&#x000a0;=&#x000a0;5) in serum-free medium. Transwell invasion through precoated basement membrane matrix, and induced by a serum gradient, was allowed to proceed for 18&#x000a0;h for all TRAP-overexpressing cell lines (<strong>f</strong>, <em>n</em>&#x000a0;=&#x000a0;4). Statistical comparison was performed on biological replicates by ANOVA test (Fig.&#x000a0;3<strong>a</strong>, <strong>b</strong>, <strong>d</strong>&#x02013;<strong>f</strong>) or t-test (Fig.&#x000a0;3
<strong>c</strong>). Groups are generally compared to their respective controls (ctrl or scr) or indicated with brackets and significance is annotated with an asterisk (*). ns&#x000a0;=&#x000a0;non-significant. &#x0201c;n=&#x0201d; indicates the number of replicates</p></div></div></div></div><div id="Sec23" class="sec"><h3 id="Sec23title">Proteomics and phosphoproteomics profiling of TRAP perturbed cells</h3><p id="Par43" class="p p-first">In order to investigate the molecular changes underlying the phenotype of TRAP-overexpressing cells, a large-scale quantitative proteomics and phosphoproteomics analyses using high-resolution isoelectric focusing (HiRIEF) fractionation [<a href="#CR47" rid="CR47" class=" bibr popnode">47</a>] coupled to LC-MS was performed. Analyses were conducted in biological duplicates and relative quantifications are expressed as ratios of TRAP3<sup>high</sup> (Heavy SILAC labeled) relative to control (Light SILAC labeled) samples.</p><p id="Par44">The proteomic analysis resulted in the identification and quantification of 7957 proteins corresponding to 7846 genes in both replicates (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span>4a</span></a>, Table&#x000a0;<a href="/pmc/articles/PMC5602878/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span>1</span></a>).

</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig4" co-legend-rid="lgnd_Fig4"><a href="/pmc/articles/PMC5602878/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140249772208128"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12885_2017_3616_Fig4_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12885_2017_3616_Fig4_HTML.jpg" src="/pmc/articles/PMC5602878/bin/12885_2017_3616_Fig4_HTML.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140249772208128"><a target="object" rel="noopener" href="/pmc/articles/PMC5602878/figure/Fig4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig4"><div><a class="figpopup" href="/pmc/articles/PMC5602878/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4">Fig. 4</a></div><!--caption a7--><div class="caption"><p>Proteomics and phosphoproteomics profiling of TRAP-overexpressing cells. Experimental workflow employed to analyze the proteome and phosphoproteome of control (ctrl, Light SILAC labeled) and TRAP3<sup>high</sup> (Heavy SILAC labeled) MDA-MB-231 cells (<em>n</em>&#x000a0;=&#x000a0;2). Protein extracts were digested with trypsin and then equal amounts of Light and Heavy peptides were pooled. Peptides were fractionated by HiRIEF using immobilized pH gradient (IPG) strips with pH range 3&#x02013;10 for proteomics analysis, and with pH range 2.5&#x02013;3.7 for phosphoproteomics analysis, prior to LC-MS analysis (<strong>a</strong>). Number of unique phospho-peptides identified in each biological replicate, broken down by number of phosphorylations (<strong>b</strong>). Protein log<sub>2</sub>(ratio H/L) (<strong>c</strong>) and phosphorylation sites normalized log<sub>2</sub>(ratio H/L) (<strong>d</strong>) distribution for the two biological replicates. A threshold for significance was set at &#x02212;/+3 MAD and &#x02212;/+ 2.5 MAD away from the median for standard proteomics and phosphoproteomics analysis respectively. &#x0201c;n=&#x0201d; indicates the number of replicates</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="Tab1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p>Analysis conditions and number of identifications for each experimental approach</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1"></th><th colspan="4" rowspan="1">TRAP3<sup>high</sup> vs control</th><th rowspan="1" colspan="1">TRAP shRNA</th></tr><tr><th rowspan="1" colspan="1"></th><th colspan="2" rowspan="1">Phosphoproteomics analysis<br />Ultra-acidic<br />(IPG 2.5&#x02013;3.7)</th><th colspan="2" rowspan="1">Standard proteomics analysis<br />Wide-range<br />(IPG 3&#x02013;10)</th><th rowspan="1" colspan="1">Wide-range<br />(IPG 3&#x02013;10)</th></tr><tr><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1">Replicate #1</th><th rowspan="1" colspan="1">Replicate #2</th><th rowspan="1" colspan="1">Replicate #1</th><th rowspan="1" colspan="1">Replicate #2</th><th rowspan="1" colspan="1"></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Nr. of unique peptides</td><td rowspan="1" colspan="1">6266</td><td rowspan="1" colspan="1">5771</td><td rowspan="1" colspan="1">79,410</td><td rowspan="1" colspan="1">81,851</td><td rowspan="1" colspan="1">97,153</td></tr><tr><td rowspan="1" colspan="1">Nr. of unique phospho-peptides</td><td rowspan="1" colspan="1">3325</td><td rowspan="1" colspan="1">3892</td><td rowspan="1" colspan="1">b</td><td rowspan="1" colspan="1">b</td><td rowspan="1" colspan="1">b</td></tr><tr><td rowspan="1" colspan="1">Nr. of unique proteins</td><td rowspan="1" colspan="1">1,704<sup>a</sup>
</td><td rowspan="1" colspan="1">1,968<sup>a</sup>
</td><td rowspan="1" colspan="1">8433</td><td rowspan="1" colspan="1">8447</td><td rowspan="1" colspan="1">9848</td></tr><tr><td rowspan="1" colspan="1">Nr. of unique genes</td><td rowspan="1" colspan="1">1,695<sup>a</sup>
</td><td rowspan="1" colspan="1">1,957<sup>a</sup>
</td><td rowspan="1" colspan="1">8309</td><td rowspan="1" colspan="1">8315</td><td rowspan="1" colspan="1">9189</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140249780576656"><a target="object" rel="noopener" href="/pmc/articles/PMC5602878/table/Tab1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p>
<sup>a</sup>For phosphoproteomics analysis the reported numbers refer only to proteins found to carry phosphorylated amino acids, and their corresponding genes</p><p>
<sup>b</sup>No phospho-peptides are reported because phosphorylation was not included as dynamic modification when searching the data</p></div></div><p id="Par45">Since TRAP possesses phosphatase activity, phosphoproteomics analysis upon TRAP overexpression was employed to identify putative TRAP targets. For phosphoproteomics analysis, HiRIEF fractionation using &#x0201c;ultra-acidic&#x0201d; pH range (2.5&#x02013;3.7) IPG strips was employed to enrich for phosphorylated peptides, as the addition of phosphate groups decreases the peptide pI. This approach led to the identification of 6266 and 5771 unique peptides in replicate 1 and replicate 2, respectively, of which 3325 and 3892 were phosphorylated (Table&#x000a0;<a href="/pmc/articles/PMC5602878/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span>1</span></a>). Across both replicates, 3290 unique phosphorylations sites corresponding to 1059 genes were identified (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span>4a</span></a>).</p><p id="Par46">Notably, these results demonstrate that HiRIEF fractionation alone can be used to perform phosphoproteomics profiling with moderate analytical depth, independently than other enrichment methods, as previously reported [<a href="#CR58" rid="CR58" class=" bibr popnode">58</a>]. This approach is particularly suitable to identify multiply phosphorylated peptides, as about 50% of the identified phospho-peptides carry two or more phosphorylations. Multiply phosphorylated peptides are enriched in the first 30 fractions (acidic end) of the IPG 2.5&#x02013;3.7 strip, while singly phosphorylated peptides are identified mostly in the more basic strip fractions (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span>4b</span></a>; Additional&#x000a0;file&#x000a0;<a href="#MOESM2" rid="MOESM2" class=" media">2</a>: Figure S1).</p><p id="Par47">Phospho-site ratios (normalized to the total protein levels) and protein ratios have Pearson coefficients of correlation between replicates of 0.60 and 0.84 respectively (Additional&#x000a0;file&#x000a0;<a href="#MOESM3" rid="MOESM3" class=" media">3</a>: Figure S2). One hundred ninety-three and 353 proteins and 116 and 58 phosphorylation sites were significantly down- and upregulated in both TRAP3<sup>high</sup> replicates (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span>4c, d</span></a>; Additional&#x000a0;file&#x000a0;<a href="#MOESM4" rid="MOESM4" class=" media">4</a>: Table S1). Among the top upregulated phosphorylation sites, S179, S180 and S183 of CD44 displayed a much higher magnitude of regulation than any other sites, with an increase of more than 11-fold in TRAP3<sup>high</sup> cells compared to control cells. These three sites located in the intracellular portion of CD44 do not have any previously reported function. The 116 phosphorylation sites downregulated in response to TRAP overexpression represent putative targets of TRAP phosphatase activity. Among the significantly downregulated phosphorylation sites, 11 sites were previously annotated to be functional, including S183 of protein phosphatase 1G (PPM1G); S131 and S137 of lysine-specific histone demethylase 1A (KDM1A); S957 and S966 of structural maintenance of chromosomes protein 1A (SMC1A); S27 of isoform 2 of X-ray repair cross-complementing protein 6 (XRCC6); and S453 and T455 of isoform 3 of Mediator of DNA damage checkpoint protein 1 (MDC1). All these sites are involved in promotion of DNA damage response. Finally, the list of genes corresponding to the significantly regulated phosphorylation sites is enriched in GO Molecular Function terms &#x0201c;cell adhesion molecule binding&#x0201d; and &#x0201c;cadherin binding&#x0201d;, as well as Cellular Component terms related to cellular junctions (Additional&#x000a0;file&#x000a0;<a href="#MOESM5" rid="MOESM5" class=" media">5</a>: Figure S3).</p><p id="Par48" class="p p-last">Additionally quantitative proteomics analysis by tandem mass tags (TMT) of scrambled and TRAP knockdown (sh2 and sh3&#x000a0;+&#x000a0;4) cells was performed in three biological replicates each (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span>5a</span></a>), identifying and quantifying 9848 proteins corresponding to 9189 genes. Quantifications for each TMT channel are expressed as ratios relative to the average of the three scrambled cell samples. Hierarchical clustering based on Euclidian distance and complete linkage separates samples based on experimental condition, illustrating good reproducibility of replicate measurements (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span>5b</span></a>). 174 and 144 proteins were significantly down- and upregulated respectively, upon TRAP knockdown in both sh2 and sh3&#x000a0;+&#x000a0;4 samples (Additional&#x000a0;file&#x000a0;<a href="#MOESM6" rid="MOESM6" class=" media">6</a>: Figure S4; marked with red row-side colors in Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span>5b</span></a>). TRAP protein expression level was significantly reduced by at least 1.5-fold in sh2 and sh3&#x000a0;+&#x000a0;4 cells.
</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig5" co-legend-rid="lgnd_Fig5"><a href="/pmc/articles/PMC5602878/figure/Fig5/" target="figure" rid-figpopup="Fig5" rid-ob="ob-Fig5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140249781561904"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12885_2017_3616_Fig5_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12885_2017_3616_Fig5_HTML.jpg" src="/pmc/articles/PMC5602878/bin/12885_2017_3616_Fig5_HTML.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140249781561904"><a target="object" rel="noopener" href="/pmc/articles/PMC5602878/figure/Fig5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig5"><div><a class="figpopup" href="/pmc/articles/PMC5602878/figure/Fig5/" target="figure" rid-figpopup="Fig5" rid-ob="ob-Fig5">Fig. 5</a></div><!--caption a7--><div class="caption"><p>Proteomics and phosphoproteomics profiling of TRAP knockdown cells. Experimental workflow applied to perform standard proteomics analysis of TRAP3<sup>high</sup> MDA-MB-231 cells transfected with a shRNA with scrambled sequence (scr, <em>n</em>&#x000a0;=&#x000a0;4) or with two different shRNAs targeting TRAP (sh2 and sh3&#x000a0;+&#x000a0;4, <em>n</em>&#x000a0;=&#x000a0;3 each) (<strong>a</strong>). Protein extracts from each condition were digested to peptides with trypsin, labeled with Tandem Mass Tags (TMT), pooled, fractionated by HiRIEF using a wide-range (pH&#x000a0;3&#x02013;10) IPG strip and analyzed by LC-MS. Heatmap representing complete linkage hierarchical clustering based on Euclidian distance of protein ratios measured in the proteomics analysis (<strong>b</strong>). Ratios are represented for each sample relative to the average of the scrambled shRNA samples (<strong>b</strong>). Row color-coding indicates significantly regulated proteins (red colored), defined by a log<sub>2</sub>(ratio) of more than &#x02212;3/+3 MAD away from the median and t-test <em>p</em>-value &#x0003c;0.01. &#x0201c;n=&#x0201d; indicates the number of replicates</p></div></div></div></div><div id="Sec24" class="sec"><h3 id="Sec24title">Proteomics and phosphoproteomics analyses of TRAP-perturbed cells reveal regulation of cell adhesion and extracellular matrix organization network</h3><p id="Par49" class="p p-first">Enrichment of gene ontology (GO) processes was evaluated comparing the list of all genes regulated upon TRAP perturbation in either of the phosphoproteomics or proteomics analyses (Additional&#x000a0;file&#x000a0;<a href="#MOESM7" rid="MOESM7" class=" media">7</a>: Table S2) with the list of all identified genes. Significantly regulated genes included 21 protein kinases, 9 protein phosphatases, 25 transcription factors and 24 ubiquitin and ubiquitin-like (UBL)-conjugating system enzymes (Additional file <a href="#MOESM7" rid="MOESM7" class=" media">7</a>: Table S2).</p><p id="Par50">Biological adhesion and ECM organization processes showed a high degree of enrichment based on significance and fold enrichment (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span>6a</span></a>). This result is in agreement with our previous observations of increased migration and invasion upon TRAP overexpression, as those processes are tightly interconnected. Additionally, we observed enrichment in processes related to mitochondrial translational termination; examination of the genes included in these processes shows that several mitochondrial ribosomal proteins were upregulated upon TRAP knockdown. As mitochondrial ribosomes translate exclusively mitochondrial encoded mRNA (13 genes, mainly electron transport chain proteins), this result might indicate increased mitochondrial protein synthesis in the mitochondria upon TRAP knockdown, possibly suggesting that TRAP affects cellular metabolism.
</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig6" co-legend-rid="lgnd_Fig6"><a href="/pmc/articles/PMC5602878/figure/Fig6/" target="figure" rid-figpopup="Fig6" rid-ob="ob-Fig6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140249764074272"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12885_2017_3616_Fig6_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12885_2017_3616_Fig6_HTML.jpg" src="/pmc/articles/PMC5602878/bin/12885_2017_3616_Fig6_HTML.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140249764074272"><a target="object" rel="noopener" href="/pmc/articles/PMC5602878/figure/Fig6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig6"><div><a class="figpopup" href="/pmc/articles/PMC5602878/figure/Fig6/" target="figure" rid-figpopup="Fig6" rid-ob="ob-Fig6">Fig. 6</a></div><!--caption a7--><div class="caption"><p>Phosphoproteomic and proteomic analyses of TRAP-perturbed cells reveal regulation of cell adhesion and extracellular matrix organization network. GO Biological Process enrichment analysis of all the genes regulated upon TRAP perturbation (842 genes, Additional&#x000a0;file&#x000a0;<a href="#MOESM7" rid="MOESM7" class=" media">7</a>: Table S2) compared to all the identified genes (9570 genes) (<strong>a</strong>). Enriched GO terms are displayed by significance of the enrichment (q-value, multiple testing corrected) and fold enrichment. Interaction network of proteins belonging to the GO terms &#x0201c;biological adhesion&#x0201d; and &#x0201c;extracellular matrix organization&#x0201d; and significantly regulated upon TRAP perturbation (<strong>b</strong>); interactions were retrieved from the STRING database. Squared shaped nodes represent proteins and round shaped nodes represent phosphorylation sites. Nodes fill color: log<sub>2</sub> transformed ratio (H/L) values for standard proteomics and phosphoproteomics analysis of TRAP3<sup>high</sup> cells (Heavy SILAC labeled) compared to control cells (Light SILAC labeled) (replicate 1 and 2 average). Nodes border color: log<sub>2</sub> transformed ratio values for standard proteomics analysis of scrambled, TRAP sh2 and sh3&#x000a0;+&#x000a0;4 cells (average of sh2 and sh3&#x000a0;+&#x000a0;4 ratios relative to scrambled)</p></div></div></div><p id="Par51">To examine the regulation of the genes specifically involved in modulating biological adhesion and ECM organization upon TRAP perturbation, we generated a protein-protein interaction network of TRAP regulated proteins classified into those GO terms, using the STRING database [<a href="#CR57" rid="CR57" class=" bibr popnode">57</a>] (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span>6b</span></a>). Proteins in the network involved with cell adhesion include protein kinases ephrin type-A receptor 2 (EPHA2), peripheral plasma membrane protein (CASK) and ROCK1 as well as receptor-type tyrosine-protein phosphatases mu, F and U (PTPRM, PTPRF and PTPRU). Interestingly, several proteins known to be involved in the migration and invasion processes were included in the network, such as matrix metalloproteases (MMPs), collagens (core components of the ECM), integrins, CD44, TGF&#x003b2;2 and T&#x003b2;R1.</p><p id="Par52" class="p p-last">Based on previous publications reporting a connection of TRAP with TGF&#x003b2; signaling through TRIP-1 and the significant upregulation of CD44 phosphorylation sites and the TGF&#x003b2; pathway-associated proteins TGF&#x003b2;2, T&#x003b2;R1 and SMAD2 measured in the SILAC proteomics analysis (Table&#x000a0;<a href="/pmc/articles/PMC5602878/table/Tab2/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab2" rid-ob="ob-Tab2" co-legend-rid=""><span>2</span></a>), we hypothesized that an activation of TGF&#x003b2; signaling or regulation of CD44 upon TRAP overexpression is responsible for the observed metastasis-related properties.
</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="Tab2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p>Expression level of TGF&#x003b2; pathway related proteins in TRAP-overexpressing MDA-MB-231 cells</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th colspan="3" rowspan="1">TRAP3<sup>high</sup> vs control</th></tr><tr><th rowspan="1" colspan="1">Gene name</th><th rowspan="1" colspan="1">Description</th><th rowspan="1" colspan="1">Protein log2(ratio H/L) &#x02013; Replicates average</th><th rowspan="1" colspan="1">Fold change (H/L) &#x02013; Replicates average</th><th rowspan="1" colspan="1">Significance<sup>a</sup>
</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">T&#x003b2;R1</td><td rowspan="1" colspan="1">TGF-beta receptor type-1</td><td rowspan="1" colspan="1">1.15</td><td rowspan="1" colspan="1">2.22</td><td rowspan="1" colspan="1">Significantly reg.</td></tr><tr><td rowspan="1" colspan="1">T&#x003b2;R2</td><td rowspan="1" colspan="1">TGF-beta receptor type-2</td><td rowspan="1" colspan="1">0.97</td><td rowspan="1" colspan="1">1.95</td><td rowspan="1" colspan="1">ns</td></tr><tr><td rowspan="1" colspan="1">T&#x003b2;R3</td><td rowspan="1" colspan="1">TGF-beta receptor type-3</td><td rowspan="1" colspan="1">0.69</td><td rowspan="1" colspan="1">1.62</td><td rowspan="1" colspan="1">ns</td></tr><tr><td rowspan="1" colspan="1">TGF&#x003b2;1</td><td rowspan="1" colspan="1">Transforming growth factor beta-1</td><td rowspan="1" colspan="1">&#x02212;0.27</td><td rowspan="1" colspan="1">0.83</td><td rowspan="1" colspan="1">ns</td></tr><tr><td rowspan="1" colspan="1">TGF&#x003b2;2</td><td rowspan="1" colspan="1">Transforming growth factor beta-2</td><td rowspan="1" colspan="1">2.25</td><td rowspan="1" colspan="1">4.77</td><td rowspan="1" colspan="1">Significantly reg.</td></tr><tr><td rowspan="1" colspan="1">TGF&#x003b2;1I1</td><td rowspan="1" colspan="1">Isoform 2 of Transforming growth factor beta-1-induced transcript&#x000a0;1 protein</td><td rowspan="1" colspan="1">&#x02212;0.42</td><td rowspan="1" colspan="1">0.75</td><td rowspan="1" colspan="1">ns</td></tr><tr><td rowspan="1" colspan="1">TGF&#x003b2; I</td><td rowspan="1" colspan="1">Transforming growth factor-beta-induced protein ig-h3</td><td rowspan="1" colspan="1">0.45</td><td rowspan="1" colspan="1">1.36</td><td rowspan="1" colspan="1">ns</td></tr><tr><td rowspan="1" colspan="1">TGIF1</td><td rowspan="1" colspan="1">TGFB-induced factor homeobox&#x000a0;1</td><td rowspan="1" colspan="1">0.80</td><td rowspan="1" colspan="1">1.75</td><td rowspan="1" colspan="1">ns</td></tr><tr><td rowspan="1" colspan="1">TGIF2</td><td rowspan="1" colspan="1">TGFB-induced factor homeobox&#x000a0;2</td><td rowspan="1" colspan="1">&#x02212;0.76</td><td rowspan="1" colspan="1">0.59</td><td rowspan="1" colspan="1">ns</td></tr><tr><td rowspan="1" colspan="1">SMAD1</td><td rowspan="1" colspan="1">Mothers against decapentaplegic homolog 1</td><td rowspan="1" colspan="1">0.19</td><td rowspan="1" colspan="1">1.14</td><td rowspan="1" colspan="1">ns</td></tr><tr><td rowspan="1" colspan="1">SMAD2</td><td rowspan="1" colspan="1">Mothers against decapentaplegic homolog 2</td><td rowspan="1" colspan="1">1.34</td><td rowspan="1" colspan="1">2.52</td><td rowspan="1" colspan="1">Significantly reg.</td></tr><tr><td rowspan="1" colspan="1">SMAD3</td><td rowspan="1" colspan="1">Mothers against decapentaplegic homolog 3</td><td rowspan="1" colspan="1">0.19</td><td rowspan="1" colspan="1">1.14</td><td rowspan="1" colspan="1">ns</td></tr><tr><td rowspan="1" colspan="1">SMAD4</td><td rowspan="1" colspan="1">Mothers against decapentaplegic homolog 4</td><td rowspan="1" colspan="1">0.78</td><td rowspan="1" colspan="1">1.72</td><td rowspan="1" colspan="1">ns</td></tr><tr><td rowspan="1" colspan="1">SMAD5</td><td rowspan="1" colspan="1">Mothers against decapentaplegic homolog 5</td><td rowspan="1" colspan="1">&#x02212;0.19</td><td rowspan="1" colspan="1">0.87</td><td rowspan="1" colspan="1">ns</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140249776724480"><a target="object" rel="noopener" href="/pmc/articles/PMC5602878/table/Tab2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p>
<sup>a</sup>Significance describes whether the level of the indicated protein is significantly altered in TRAP3<sup>high</sup> compared to control cells, based on cutoffs for log<sub>2</sub>(ratio) of &#x02212;/+ 2.5 MAD away from the median (see Material and methods). &#x0201c;ns&#x0201d; indicates that the measured protein level is not significantly changed in TRAP3<sup>high</sup> cells</p></div></div></div><div id="Sec25" class="sec sec-last"><h3 id="Sec25title">TRAP effects on proliferation and migration are mediated via TGF&#x003b2; pathway-associated proteins</h3><p id="Par53" class="p p-first">To consolidate our hypothesis, protein expression of the most upregulated TGF&#x003b2; pathway protein, TGF&#x003b2;2, was quantified in TRAP3<sup>high</sup> cells and compared to control cells (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig7" rid-ob="ob-Fig7" co-legend-rid="lgnd_Fig7"><span>7</span></a>). Concordantly with the global analysis, TGF&#x003b2;2 protein was upregulated in TRAP3<sup>high</sup> cells as shown by both immunocytochemistry (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig7" rid-ob="ob-Fig7" co-legend-rid="lgnd_Fig7"><span>7a, b</span></a>) and Western blotting (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig7" rid-ob="ob-Fig7" co-legend-rid="lgnd_Fig7"><span>7c, d</span></a>). Additionally, TGF&#x003b2;2 expression was reduced to control cell level upon inhibition with the TRAP inhibitor 5-PNA (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig7" rid-ob="ob-Fig7" co-legend-rid="lgnd_Fig7"><span>7c, d</span></a>).
</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig7" co-legend-rid="lgnd_Fig7"><a href="/pmc/articles/PMC5602878/figure/Fig7/" target="figure" rid-figpopup="Fig7" rid-ob="ob-Fig7"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140249777043840"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12885_2017_3616_Fig7_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12885_2017_3616_Fig7_HTML.jpg" src="/pmc/articles/PMC5602878/bin/12885_2017_3616_Fig7_HTML.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140249777043840"><a target="object" rel="noopener" href="/pmc/articles/PMC5602878/figure/Fig7/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig7"><div><a class="figpopup" href="/pmc/articles/PMC5602878/figure/Fig7/" target="figure" rid-figpopup="Fig7" rid-ob="ob-Fig7">Fig. 7</a></div><!--caption a7--><div class="caption"><p>TRAP overexpression upregulates TGF&#x003b2;-pathway associated proteins. Expression of TGF&#x003b2;2, respectively after 24&#x000a0;h treatment with the small molecule TRAP inhibitor 5-PNA (200&#x000a0;&#x003bc;M) or respective control in complete medium. Quantification of Immunocytochemistry (<strong>a</strong>, <strong>b</strong>, <em>n</em>&#x000a0;=&#x000a0;3) and Western blotting (<strong>c</strong>, <strong>d</strong>, <em>n</em>&#x000a0;=&#x000a0;4). One representative image of immunocytochemistry staining (<strong>a</strong>, TGF&#x003b2;2, green; Hoechst, blue) or blot (<strong>c</strong>, TGF&#x003b2;2, 48&#x000a0;kDa; normalization control &#x003b2;-Actin 42&#x000a0;kDa) is shown. Quantification was performed by analysis of fluorescent intensities per cell for immunocytochemistry (<strong>b</strong>) and by densitometry for western blot analysis (<strong>d</strong>). Statistical comparison was performed on biological replicates by or t-test (Fig.&#x000a0;7
<strong>b</strong>) or ANOVA test (Fig.&#x000a0;7
<strong>d</strong>). Groups are generally compared to their respective controls (ctrl, untreated) or indicated with brackets and significance is annotated with an asterisk (*). ns&#x000a0;=&#x000a0;non-significant. &#x0201c;n=&#x0201d; indicates the number of replicates</p></div></div></div><p id="Par54">To examine the functional impact of TGF&#x003b2;2/T&#x003b2;R in TRAP3<sup>high</sup> cells, we assayed cell proliferation and migration upon treatment with blocking antibodies against TGF&#x003b2;2 (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig8/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig8" rid-ob="ob-Fig8" co-legend-rid="lgnd_Fig8"><span>8a-c</span></a>) or with a small molecule inhibiting T&#x003b2;R1/2 (LY2109761; Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig8/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig8" rid-ob="ob-Fig8" co-legend-rid="lgnd_Fig8"><span>8d-f</span></a>). Blocking of either TGF&#x003b2;2 or T&#x003b2;R1/2 kinase activity reduced the proliferation of TRAP3<sup>high</sup> cells to the level of control cells (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig8/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig8" rid-ob="ob-Fig8" co-legend-rid="lgnd_Fig8"><span>8a, d</span></a>). Furthermore, interfering with the TGF&#x003b2; pathway-associated proteins decreased migration (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig8/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig8" rid-ob="ob-Fig8" co-legend-rid="lgnd_Fig8"><span>8b, c, e, f</span></a>) in TRAP3<sup>high</sup> cells to the levels detected in the control cells. Migration curves over 30&#x000a0;h are shown in Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig8/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig8" rid-ob="ob-Fig8" co-legend-rid="lgnd_Fig8"><span>8c and f</span></a>. Control cell proliferation or migration were not affected when interfering with the TGF&#x003b2; pathway associated proteins by using blocking antibodies against TGF&#x003b2;2 or the small molecule inhibiting T&#x003b2;R1/2 activity (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig8/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig8" rid-ob="ob-Fig8" co-legend-rid="lgnd_Fig8"><span>8a-f</span></a>). Treatment with the closely related ligand TGF&#x003b2;1 did not affect proliferation and migration of control and TRAP3<sup>high</sup> cells (Additional&#x000a0;file&#x000a0;<a href="#MOESM8" rid="MOESM8" class=" media">8</a>: Figure S5).
</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig8" co-legend-rid="lgnd_Fig8"><a href="/pmc/articles/PMC5602878/figure/Fig8/" target="figure" rid-figpopup="Fig8" rid-ob="ob-Fig8"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140249772331776"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12885_2017_3616_Fig8_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12885_2017_3616_Fig8_HTML.jpg" src="/pmc/articles/PMC5602878/bin/12885_2017_3616_Fig8_HTML.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140249772331776"><a target="object" rel="noopener" href="/pmc/articles/PMC5602878/figure/Fig8/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig8"><div><a class="figpopup" href="/pmc/articles/PMC5602878/figure/Fig8/" target="figure" rid-figpopup="Fig8" rid-ob="ob-Fig8">Fig. 8</a></div><!--caption a7--><div class="caption"><p>TRAP-dependent proliferation and migration are mediated via the TGF&#x003b2;2/T&#x003b2;R and CD44. Functional analysis after treatment with a blocking antibody anti-TGF&#x003b2;2 (0.25&#x000a0;&#x003bc;g/mL, <strong>a</strong>-<strong>c</strong>, <em>n</em>&#x000a0;=&#x000a0;6), the small molecule inhibitor LY2109761 against TGF&#x003b2; receptor type 1/type 2 kinase activity (2&#x000a0;&#x003bc;M, <strong>d</strong>-<strong>f</strong>, <em>n</em>&#x000a0;=&#x000a0;4) or with a blocking antibody anti-CD44 (10&#x000a0;&#x003bc;g/mL, <strong>g</strong>-<strong>i</strong>, <em>n</em>&#x000a0;=&#x000a0;3) and respective controls. Proliferation was assessed after 24&#x000a0;h treatment in complete medium (<strong>a</strong>, <strong>d</strong>, <strong>g</strong>). Live cell imaging was performed over 30&#x000a0;h in serum-free medium containing blocking antibody or small chemical inhibitor and wound migration velocity (<strong>b</strong>, <strong>e</strong>, <strong>h</strong>) and migration curves (<strong>c</strong>, <strong>f</strong>, <strong>i</strong>) are compared. Statistical comparison was performed on biological replicates by ANOVA test. Groups are generally compared to their respective controls (ctrl, untreated) or indicated with brackets and significance is annotated with an asterisk (*). ns&#x000a0;=&#x000a0;non-significant. &#x0201c;n=&#x0201d; indicates the number of replicates</p></div></div></div><p id="Par55" class="p p-last">As discovered by phosphoproteomics analysis, phosphorylation of S179, S180 and S183 of CD44 was increased more than 11-fold in TRAP3<sup>high</sup> compared to control cells, representing the top upregulated phospho-events in TRAP3<sup>high</sup> cells. These three phosphorylation sites are located in the intracellular domain of CD44 and do not have any previously reported function. No antibodies targeting those phosphorylation sites are currently available, thus we probed the role of CD44 in determining the TRAP-dependent phenotype by inhibiting CD44 using a blocking antibody (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig8/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig8" rid-ob="ob-Fig8" co-legend-rid="lgnd_Fig8"><span>8g-i</span></a>). Upon anti-CD44 treatment, the proliferation rate of TRAP3<sup>high</sup> cells was reduced to a level lower than that of control cells (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig8/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig8" rid-ob="ob-Fig8" co-legend-rid="lgnd_Fig8"><span>8g</span></a>), while the TRAP-dependent increase in migration was not affected (Fig.&#x000a0;<a href="/pmc/articles/PMC5602878/figure/Fig8/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig8" rid-ob="ob-Fig8" co-legend-rid="lgnd_Fig8"><span>8h, i</span></a>).</p></div></div><div id="Sec26" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec26title">Discussion</h2><p id="Par56" class="p p-first">TRAP has been shown to be associated with tumor progression in several types of cancer and suggested to be clinically relevant as a marker for peritoneal dissemination in gastric cancer [<a href="#CR20" rid="CR20" class=" bibr popnode">20</a>&#x02013;<a href="#CR22" rid="CR22" class=" bibr popnode">22</a>]. Recently, TRAP was identified as a pro-invasion oncogene and a prognostic marker in melanoma [<a href="#CR20" rid="CR20" class=" bibr popnode">20</a>]. Moreover, TRAP&#x02019;s functional role in invasion, cell motility and metastasis was suggested to be mediated through phosphorylation of focal adhesion complexes [<a href="#CR20" rid="CR20" class=" bibr popnode">20</a>].</p><p id="Par57">In this study, we investigated the effects of TRAP expression on cell properties related to the development of metastasis and on the cellular signaling of the MDA-MB-231 breast cancer cell line at the system level. The small molecule 5-phenylnicotinic acid (5-PNA), recently identified as a specific inhibitor of TRAP activity and TRAP-dependent migration and invasion, was employed as a tool to investigate the molecular events mediated by TRAP [<a href="#CR45" rid="CR45" class=" bibr popnode">45</a>, <a href="#CR59" rid="CR59" class=" bibr popnode">59</a>]. We demonstrate that TRAP regulates metastasis-related features such as anchorage-independent and &#x02013;dependent cell growth, proliferation, migration and invasion. Global proteomics and phosphoproteomic analyses showed that regulated events upon TRAP perturbation are mainly proteins and phosphorylation sites involved with cellular adhesion and extracellular matrix (ECM) organization. Based on these analyses and on the literature, we hypothesized that TGF&#x003b2; pathway-associated proteins and three previously unreported intracellular phosphorylation sites of CD44 mediate the observed TRAP-dependent cellular phenotypic properties.</p><p id="Par58">TRAP has been proposed as a differentiation and growth factor for cells of hematopoietic origin [<a href="#CR60" rid="CR60" class=" bibr popnode">60</a>]. Effects of TRAP expression on cell transformation and tumor progression have been clinically validated in melanoma, as well as proven in vitro by an anchorage-independent growth assay [<a href="#CR20" rid="CR20" class=" bibr popnode">20</a>]. TRAP overexpression correlates with increased tumor size and poor differentiation in hepatocellular cancer [<a href="#CR21" rid="CR21" class=" bibr popnode">21</a>]. We consolidated and expanded these findings by using the breast cancer cell line MDA-MB-231, showing that TRAP overexpression increases cell growth as well as colony formation and cell proliferation above basal levels. Moreover, a higher number of TRAP-overexpressing cells compared to control cells were actively proliferating after 48&#x000a0;h serum starvation, indicating a lower requirement for exogenous growth stimulation.</p><p id="Par59">Morphological changes such as cell rounding or cell spreading upon perturbation of TRAP expression have been reported in melanoma cells [<a href="#CR20" rid="CR20" class=" bibr popnode">20</a>]. Modulation of TRAP expression was shown to impact the migration and invasion of melanoma and hepatocellular carcinoma cells both in vitro and in vivo<em>,</em> when either non-invasive cancer cells, expressing low amounts of TRAP or metastatic high-TRAP expressing cells were subjected to upregulation or knockdown, respectively [<a href="#CR20" rid="CR20" class=" bibr popnode">20</a>, <a href="#CR21" rid="CR21" class=" bibr popnode">21</a>]. Moreover, also in non-malignant epithelial cells TRAP expression was linked to a regulation of cell migration [<a href="#CR61" rid="CR61" class=" bibr popnode">61</a>]. This study demonstrates that TRAP overexpression enhances the elongated phenotype, migration and invasion capabilities of invasive breast cancer cells. Importantly, the elongated morphology and migration were regulated by TRAP in a dose-dependent manner. The presence of ECM proteins and basement membrane proteins Collagen IV and Laminin I increased transwell migration of TRAP3<sup>high</sup> cells as compared to control cells, underscoring the role of TRAP during the invasive process. Transwell migration was particularly increased in the presence of osteopontin (OPN), a highly phosphorylated ECM protein previously suggested to be a physiological substrate for TRAP [<a href="#CR10" rid="CR10" class=" bibr popnode">10</a>], and involved in the progression of TRAP-related pathologies such as the immuno-osseous disorder Spondyloenchondrodysplasia [<a href="#CR9" rid="CR9" class=" bibr popnode">9</a>, <a href="#CR62" rid="CR62" class=" bibr popnode">62</a>]. OPN has been reported as a ligand to the CD44 receptor [<a href="#CR41" rid="CR41" class=" bibr popnode">41</a>] and was shown to increase osteoclast migration [<a href="#CR8" rid="CR8" class=" bibr popnode">8</a>], which is blunted upon antibody-mediated blocking of CD44 [<a href="#CR63" rid="CR63" class=" bibr popnode">63</a>]. Inhibition of TRAP by the small molecule inhibitor 5-PNA was previously reported to decrease TRAP3<sup>high</sup> cells migration and invasion [<a href="#CR45" rid="CR45" class=" bibr popnode">45</a>]; here we showed that also proliferation of TRAP3<sup>high</sup> cells is reduced to basal levels upon treatment with 5-PNA, altogether providing evidence that the above mentioned phenotypes of TRAP-overexpressing MDA-MB-231 cells are attributable to the overexpression of TRAP.</p><p id="Par60">In parallel, global proteomics analysis of TRAP3<sup>high</sup> cells revealed regulation of various proteins belonging to the GO terms &#x0201c;biological adhesion&#x0201d; and &#x0201c;ECM organization&#x0201d;. Coherently, an increase in migration and invasion on various ECM and basement membrane proteins was observed in the TRAP3<sup>high</sup> cells. Enrichment in closely related GO terms, such as &#x0201c;cell adhesion molecule binding&#x0201d; and &#x0201c;cell junction&#x0201d;, was noted when analyzing phosphosites regulated in TRAP-overexpressing cells compared to control cells, further substantiating the involvement of TRAP in these functions. The list of 119 phosphorylation sites downregulated upon TRAP overexpression represent an inventory of putative targets of TRAP phosphatase activity or possible signaling intermediates; among those, eight sites with known regulatory function are involved in DNA damage response, another hallmark of cancer.</p><p id="Par61">Most importantly, we identified a regulation of the TGF&#x003b2; pathway-associated proteins TGF&#x003b2;2, T&#x003b2;R1 and SMAD2, as well as a highly significant upregulation of previously unreported phosphorylation sites of CD44 upon TRAP perturbation in the MDA-MB-231 breast cancer cell line. Quantification of expression levels by several methodological approaches confirmed the upregulation of the ligand TGF&#x003b2;2, which could be reverted by treatment with the TRAP inhibitor 5-PNA. Functional blocking of TGF&#x003b2;2 or inhibition of T&#x003b2;R1/2 kinase activity restrained the increase in migration and proliferation promoted by TRAP. Antibody-mediated inhibition of CD44 reduced proliferation beyond the basal level of control cells.</p><p id="Par62">Several reports support the concept that TGF&#x003b2; promotes or restrains cell proliferation depending on the context [<a href="#CR28" rid="CR28" class=" bibr popnode">28</a>]. TGF&#x003b2; inhibited the proliferation of most epithelial cells and its growth inhibitory effect could be partially reverted by treatment with a specific inhibitor [<a href="#CR64" rid="CR64" class=" bibr popnode">64</a>&#x02013;<a href="#CR66" rid="CR66" class=" bibr popnode">66</a>]. Poorly differentiated prostate cancer cells were resistant to TGF&#x003b2; growth inhibitory effect in vivo [<a href="#CR67" rid="CR67" class=" bibr popnode">67</a>]<em>.</em> Upon functional blocking of TGF&#x003b2;2 or inhibition of T&#x003b2;R1/2 kinase activity, we observed decreased proliferation of TRAP-overexpressing cells but not of control MDA-MB-231 cells. Such lack of response in the control cells suggests that the malignant MDA-MB-231 cells are resistant to the growth-inhibitory effect of TGF&#x003b2;, and that TRAP-dependent increase in proliferation of TRAP-overexpressing cells is TGF&#x003b2;2-mediated. Furthermore, the invasive capacity of malignant breast cancer cells is enhanced by TGF&#x003b2;1 [<a href="#CR68" rid="CR68" class=" bibr popnode">68</a>] and inactivation of TGF&#x003b2; signaling inhibited invasiveness in vitro and in vivo for colon carcinoma cell lines [<a href="#CR69" rid="CR69" class=" bibr popnode">69</a>]. Additionally, here we detected a TRAP-dependent promotion of migration mediated by TGF&#x003b2;2.</p><p id="Par63">We could exclude a possible contribution of TGF&#x003b2;1 because treatment with this TGF&#x003b2; ligand modulated neither migration nor proliferation, as reported previously, despite constitutive expression of its receptors [<a href="#CR68" rid="CR68" class=" bibr popnode">68</a>]. Thereby we substantiated that the TGF&#x003b2;2 isoform is crucial for the TRAP-mediated effects. In support to this notion, TGF&#x003b2;2 was previously attributed a dominant role in predicting the outcome of breast cancers [<a href="#CR38" rid="CR38" class=" bibr popnode">38</a>] and aberrant expression of the TGF&#x003b2;2 isoform exclusively was induced through an autocrine loop in glioma [<a href="#CR39" rid="CR39" class=" bibr popnode">39</a>].</p><p id="Par64">We were also interested in the regulation of CD44, as it has previously been reported to be connected to TGF&#x003b2; pathway [<a href="#CR70" rid="CR70" class=" bibr popnode">70</a>&#x02013;<a href="#CR72" rid="CR72" class=" bibr popnode">72</a>] and to be phosphorylated by TR&#x003b2;1 [<a href="#CR40" rid="CR40" class=" bibr popnode">40</a>]. Our analysis identified three phosphorylation sites of CD44 as the top upregulated phosphorylation events in TRAP3<sup>high</sup> cells. Additionally, CD44 is a receptor for OPN [<a href="#CR41" rid="CR41" class=" bibr popnode">41</a>], which is the protein that prominently increased transwell migration in TRAP-overexpressing cells in this study. Functional blocking of CD44 resulted in a decrease of proliferation of TRAP3<sup>high</sup> cells beyond the basal level of control cells, but had no effect on cell migration. This suggests that cell migration is regulated by TRAP via TGF&#x003b2; independently of CD44, but that the basal and TRAP-dependent proliferative activity of the TRAP3<sup>high</sup> cells is regulated through both TGF&#x003b2; signaling and CD44.</p><p id="Par65" class="p p-last">As this study is performed in vitro and uses a metastatic cell line, similar experiments in other cancer cell lines at different stages of metastatic progression would be crucial to fully delineate the effects of TRAP, possibly revealing a role in promoting metastasis of non-invasive cell lines as well [<a href="#CR20" rid="CR20" class=" bibr popnode">20</a>, <a href="#CR21" rid="CR21" class=" bibr popnode">21</a>]. Additionally, knockdown of TRAP in invasive cancer cells expressing high TRAP levels might be employed to test whether their invasive phenotype is TRAP-dependent. Limitations include also a full dissection of the respective TGF&#x003b2; pathway and a reconfirmation, to allow for a generalization to other TRAP expressing cell lines.</p></div><div id="Sec27" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec27title">Conclusion</h2><p id="Par66" class="p p-first-last">This is the first study investigating the effects of TRAP perturbation in cancer cells on a global scale and identifying possible substrates and signaling intermediates. Herein, we show that TRAP promotes metastasis-related cellular properties, such as cancer cell proliferation, migration and invasion beyond basal levels in malignant breast cancer cells and regulates cell adhesion and extracellular matrix (ECM) organization. TRAP-dependent migration and proliferation can be neutralized upon inhibition of TGF&#x003b2;2/TR&#x003b2; and CD44 or inhibition of TRAP by the small molecule 5-PNA. Altogether, this data provide the basis for further studies investigating TRAP signaling and a novel possible targeting strategy for the treatment of tumors with high TRAP expression.</p></div><div id="sec-a.w.f" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="sec-a.w.ftitle">Additional files</h2><!--/article/body/sec/--><div id="Sec28" class="sec sec-first-last"><p class="p p-first-last">
</p><div class="sec suppmat" id="MOESM1"><div class="sup-box half_rhythm" id="media-a.w.f.b.a.a.a"><a href="/pmc/articles/PMC5602878/bin/12885_2017_3616_MOESM1_ESM.docx" data-ga-action="click_feat_suppl">Additional file 1: Material and Methods.</a><sup>(32K, docx)</sup><p>Additional explanations on Material and Methods including descriptions of gene expression analysis, cell lysis, SILAC labeling, protein extraction for mass spectrometric analyses, protein digestion, Tandem Mass Tag labeling, liquid chromatography tandem mass spectrometric analyses and proteomics database search, protein and phospho-peptide ratios calculation. (DOCX 32 kb)</p></div></div><p>
</p><div class="sec suppmat" id="MOESM2"><div class="sup-box half_rhythm" id="media-a.w.f.b.a.b.a"><a href="/pmc/articles/PMC5602878/bin/12885_2017_3616_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl">Additional file 2: Figure S1.</a><sup>(149K, pdf)</sup><p>Distribution of unique peptides across fractions generated by HiRIEF separation on IPG 2.5&#x02013;3.7 strips. Number of unique peptides and phospho-peptides identified across fractions in each biological replicate (A) and (B), displayed by number of phosphorylations. Fraction numbering proceeds from the acidic end towards the basic end of the strips. Multiply phosphorylated peptides are identified prevalently in the first 30 fractions in the IPG 2.5&#x02013;3.7 strip. (PDF 148 kb)</p></div></div><p>
</p><div class="sec suppmat" id="MOESM3"><div class="sup-box half_rhythm" id="media-a.w.f.b.a.c.a"><a href="/pmc/articles/PMC5602878/bin/12885_2017_3616_MOESM3_ESM.pdf" data-ga-action="click_feat_suppl">Additional file 3: Figure S2.</a><sup>(2.8M, pdf)</sup><p>Quantitative reproducibility of biological replicates employed for phosphoproteomics and proteomics analysis of TRAP3<sup>high</sup> (Heavy SILAC labeled) and control (Light SILAC labeled) MDA-MB-231 cells. Correlation of log<sub>2</sub> transformed ratio (H/L) values for replicate pairs for phosphoproteomics analysis (A) and standard proteomics analysis (B); Pearson correlation coefficient is displayed. (PDF 2872 kb)</p></div></div><p>
</p><div class="sec suppmat" id="MOESM4"><div class="sup-box half_rhythm" id="media-a.w.f.b.a.d.a"><a href="/pmc/articles/PMC5602878/bin/12885_2017_3616_MOESM4_ESM.xlsx" data-ga-action="click_feat_suppl">Additional file 4: Table S1.</a><sup>(48K, xlsx)</sup><p>Phosphorylation sites significantly regulated in TRAP3<sup>high</sup> cells compared to control (ctrl) cells. Unique phosphorylation sites are defined by a sequence window of 15 amino acids centered at the phosphorylated residue. The column &#x0201c;Protein class&#x0201d; describes to which of the examined protein class a protein belongs to. Examined proteins classes include protein kinases, protein phosphatases, ubiquitin and UBL system enzymes and transcription factors. The column &#x0201c;Functional site&#x0201d; describes whether the phospho-site has a known regulatory function based on the information available on the database PhosphoSitePlus. (XLSX 48 kb)</p></div></div><p>
</p><div class="sec suppmat" id="MOESM5"><div class="sup-box half_rhythm" id="media-a.w.f.b.a.e.a"><a href="/pmc/articles/PMC5602878/bin/12885_2017_3616_MOESM5_ESM.pdf" data-ga-action="click_feat_suppl">Additional file 5: Figure S3.</a><sup>(5.0M, pdf)</sup><p>Volcano plots representing the selection of proteins significantly regulated upon TRAP knockdown in TRAP3<sup>high</sup> MDA-MB-231 cells. The average log<sub>2</sub> transformed ratio of the three replicates is plotted for each experimental condition. Significantly regulated events are defined by log<sub>2</sub> transformed ratios at least &#x02212;/+3 MAD away from the median and <em>p</em>-values lower than 0.01. TRAP sh2 samples versus scrambled (A). TRAP sh3&#x000a0;+&#x000a0;4 samples vs scrambled (B). (PDF 5171 kb)</p></div></div><p>
</p><div class="sec suppmat" id="MOESM6"><div class="sup-box half_rhythm" id="media-a.w.f.b.a.f.a"><a href="/pmc/articles/PMC5602878/bin/12885_2017_3616_MOESM6_ESM.pdf" data-ga-action="click_feat_suppl">Additional file 6: Figure S4.</a><sup>(86K, pdf)</sup><p>GO enrichment analyses of genes corresponding to phosphorylation sites significantly regulated upon TRAP overexpression in MDA-MB-231 cells. GO terms enrichment was evaluated for the set of genes corresponding to phospho-sites significantly regulated in TRAP3<sup>high</sup> cells (99 genes) compared to the set of genes identified across all proteomics analyses (9570 genes). Enriched GO terms are displayed by significance of the enrichment (q-value, multiple testing corrected) and fold enrichment. GO Molecular Function enrichment analysis (A). GO Cell Component enrichment analysis (B). (PDF 86 kb)</p></div></div><p>
</p><div class="sec suppmat" id="MOESM7"><div class="sup-box half_rhythm" id="media-a.w.f.b.a.g.a"><a href="/pmc/articles/PMC5602878/bin/12885_2017_3616_MOESM7_ESM.xlsx" data-ga-action="click_feat_suppl">Additional file 7: Table S2.</a><sup>(80K, xlsx)</sup><p>Proteins significantly regulated upon TRAP perturbation in any of the phosphoproteomics or proteomics analyses (TRAP3<sup>high</sup> vs ctrl, phospho and standard proteomics analyses; TRAP sh2 or sh3&#x000a0;+&#x000a0;4 vs scrambled shRNA, standard proteomics analysis). The column &#x0201c;Enriched GO term&#x0201d; specifies whether the protein belong to any of the GO terms that were found to be enriched in the list of regulated proteins. The column &#x0201c;Protein class&#x0201d; describes to which of the examined protein class a protein belongs to. Examined proteins classes include protein kinases, protein phosphatases, ubiquitin and UBL system enzymes and transcription factors. (XLSX 79 kb)</p></div></div><p>
</p><div class="sec suppmat" id="MOESM8"><div class="sup-box half_rhythm" id="media-a.w.f.b.a.h.a"><a href="/pmc/articles/PMC5602878/bin/12885_2017_3616_MOESM8_ESM.pdf" data-ga-action="click_feat_suppl">Additional file 8: Figure S5.</a><sup>(952K, pdf)</sup><p>Functional analysis after treatment with TGF&#x003b2;1 (10&#x000a0;&#x003bc;g/mL, A, B, <em>n</em>&#x000a0;=&#x000a0;5) and respective controls. Live cell imaging was performed over 30&#x000a0;h in serum-free medium containing blocking antibody or small molecule inhibitor and wound migration velocity (A) and migration curves are compared. Cell proliferation was assessed after 24&#x000a0;h treatment in complete medium (B). Statistical comparison was performed on biological replicates by ANOVA test. Groups are generally compared to their respective controls (ctrl, untreated) or indicated with brackets and significance is annotated with an asterisk (*). ns&#x000a0;=&#x000a0;non-significant. &#x0201c;n=&#x0201d; indicates the number of replicates. (PDF 952 kb)</p></div></div><p>
</p></div></div><div id="ack-a.x.c" class="tsec sec"><h2 class="head no_bottom_margin" id="ack-a.x.ctitle">Acknowledgements</h2><div class="sec"><p>The authors would like to thank Shuvojit Moulik, Melanie Weiss and Joseph Azem for their assistance in laboratory preparations.</p><div id="FPar1" class="sec"><h3 id="FPar1title">Funding</h3><p id="Par67" class="p p-first-last">This work was funded by the Swedish Research Council and supported by grants supplied from the Swedish Cancer Society, the Cancer Society Stockholm and the Swedish Foundation for Strategic Research. Funding bodies did not have any influence in the design of the study and collection, analysis and interpretation of data or in writing the manuscript.</p></div><div id="FPar2" class="sec sec-last"><h3 id="FPar2title">Availability of data and materials</h3><p id="Par68" class="p p-first-last">The datasets generated and/or analyzed during the current study are available in the ProteomeXchange/ PRIDE database: &#x0201c;Proteomic and phosphoproteomics profiling of breast cancer cells with altered expression level of the protein phosphatase TRAP&#x0201d;, dataset identifier PXD006430 (<a href="https://www.ebi.ac.uk/pride/archive/login" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://www.ebi.ac.uk/pride/archive/login</a>). Other raw data generated and/or analyzed during the current study are available from the corresponding author on reasonable request.</p></div></div></div><div id="glossary-a.x.a" class="tsec sec"><h2 class="head no_bottom_margin" id="glossary-a.x.atitle">Abbreviations</h2><div class="bk-sec"><div><table class="default-table glossary"><tbody><tr><td>5-PNA</td><td>5-phenylnicotinic acid</td></tr><tr><td>CD44</td><td>Cluster of differentiation 44</td></tr><tr><td>OPN</td><td>Osteopontin</td></tr><tr><td>TGF&#x003b2;</td><td>Transforming growth factor &#x003b2;</td></tr><tr><td>TRAP/ACP5</td><td>Tartrate-resistant acid phosphatase</td></tr><tr><td>T&#x003b2;R</td><td>Transforming growth factor receptor &#x003b2;</td></tr></tbody></table></div></div></div><div id="notes-a.x.d" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.x.dtitle">Authors&#x02019; contributions</h2><p>AR, EP, MK, JL, BER, GA contributed to the Conception and design of the work. (Functional) cell experiments and analyses were conducted by AR. Phosphoproteomic and Proteomic analysis was performed by EP, with help from MK. Data were analyzed and interpreted by AR, EP, LO, RMB, BER, GA. The article was drafted by AR, EP and revised by JL, LO, RMB, BER and GA. All authors read and approved the manuscript. The study was supervised by JL, LO, RMB, BER, GA.</p></div><div id="notes-a.x.e" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.x.etitle">Notes</h2><div id="FPar3" class="sec sec-first"><h2 id="FPar3title">Ethics approval and consent to participate</h2><p id="Par69" class="p p-first-last">Not applicable.</p></div><div id="FPar4" class="sec"><h2 id="FPar4title">Consent for publication</h2><p id="Par70" class="p p-first-last">Not applicable.</p></div><div id="FPar5" class="sec"><h2 id="FPar5title">Competing interests</h2><p id="Par71" class="p p-first-last">The authors declare that they do not have any competing interests.</p></div><div id="FPar6" class="sec sec-last"><h2 id="FPar6title">Publisher&#x02019;s Note</h2><p id="Par72" class="p p-first-last">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div></div><div id="fn-group-a.x.b" class="tsec sec"><h2 class="head no_bottom_margin" id="fn-group-a.x.btitle">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="fn-a.x.b.a"><p class="p p-first"><strong>Electronic supplementary material</strong></p><p class="p p-last">The online version of this article doi:(10.1186/s12885-017-3616-7) contains supplementary material, which is available to authorized users.</p></p></div></div><div id="article-aaff-info" class="tsec sec"><h2 class="head no_bottom_margin" id="article-aaff-infotitle">Contributor Information</h2><p><span class="fm-affl">Anja Reithmeier, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="es.ik@reiemhtier.ajna" class="oemail">es.ik@reiemhtier.ajna</a></span>.</p><p><span class="fm-affl">Elena Panizza, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="es.ik@azzinaP.anelE" class="oemail">es.ik@azzinaP.anelE</a></span>.</p><p><span class="fm-affl">Michael Krumpel, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamg@lepmurk" class="oemail">moc.liamg@lepmurk</a></span>.</p><p><span class="fm-affl">Lukas M. Orre, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="es.ik@errO.sakuL" class="oemail">es.ik@errO.sakuL</a></span>.</p><p><span class="fm-affl">Rui M. M. Branca, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="es.ik@acnarB-edemaM.iuR" class="oemail">es.ik@acnarB-edemaM.iuR</a></span>.</p><p><span class="fm-affl">Janne Lehti&#x000f6;, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="es.ik@oitheL.ennaJ" class="oemail">es.ik@oitheL.ennaJ</a></span>.</p><p><span class="fm-affl">Barbro Ek-Rylander, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="es.ik@rednalyr-ke.orbrab" class="oemail">es.ik@rednalyr-ke.orbrab</a></span>.</p><p><span class="fm-affl">G&#x000f6;ran Andersson, </span><span class="fm-affl">Phone: +46858581031, <span class="email-label">Email: </span><a href="mailto:dev@null" data-email="es.ik@nossredna.naroG" class="oemail">es.ik@nossredna.naroG</a></span>.</p></div><div id="Bib1" class="tsec sec"><h2 class="head no_bottom_margin" id="Bib1title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CR1">1. <span class="element-citation">Oddie GW, Schenk G, Angel NZ, Walsh N, Guddat LW, de Jersey J, et al. Structure, function, and regulation of tartrate-resistant acid phosphatase. <span><span class="ref-journal">Bone [Internet] </span>2000;<span class="ref-vol">27</span>:575–584. doi: 10.1016/S8756-3282(00)00368-9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11062342" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2FS8756-3282(00)00368-9" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bone+[Internet]&amp;title=Structure,+function,+and+regulation+of+tartrate-resistant+acid+phosphatase&amp;author=GW+Oddie&amp;author=G+Schenk&amp;author=NZ+Angel&amp;author=N+Walsh&amp;author=LW+Guddat&amp;volume=27&amp;publication_year=2000&amp;pages=575-584&amp;doi=10.1016/S8756-3282(00)00368-9&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR2">2. <span class="element-citation">Ljusberg J, Ek-Rylander B, Andersson G. Tartrate-resistant purple acid phosphatase is synthesized as a latent proenzyme and activated by cysteine proteinases. <span><span class="ref-journal">Biochem J [Internet] </span>1999;<span class="ref-vol">343 Pt 1</span>:63–69. doi: 10.1042/bj3430063.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1220524/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10493912" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1042%2Fbj3430063" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+J+[Internet]&amp;title=Tartrate-resistant+purple+acid+phosphatase+is+synthesized+as+a+latent+proenzyme+and+activated+by+cysteine+proteinases&amp;author=J+Ljusberg&amp;author=B+Ek-Rylander&amp;author=G+Andersson&amp;volume=343+Pt+1&amp;publication_year=1999&amp;pages=63-69&amp;pmid=10493912&amp;doi=10.1042/bj3430063&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR3">3. <span class="element-citation">Uppenberg J, Lindqvist F, Svensson C, Ek-Rylander B, Andersson G. Crystal structure of a mammalian purple acid phosphatase. <span><span class="ref-journal">J Mol Biol. </span>1999;<span class="ref-vol">290</span>:201–211. doi: 10.1006/jmbi.1999.2896.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10388567" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1006%2Fjmbi.1999.2896" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Mol+Biol&amp;title=Crystal+structure+of+a+mammalian+purple+acid+phosphatase&amp;author=J+Uppenberg&amp;author=F+Lindqvist&amp;author=C+Svensson&amp;author=B+Ek-Rylander&amp;author=G+Andersson&amp;volume=290&amp;publication_year=1999&amp;pages=201-211&amp;pmid=10388567&amp;doi=10.1006/jmbi.1999.2896&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR4">4. <span class="element-citation">Ek-Rylander B, Bill P, Norg&#x000e5;rd M, Nilsson S, Andersson G. Cloning, sequence, and developmental expression of a type 5, tartrate-resistant, acid phosphatase of rat bone. <span><span class="ref-journal">J Biol Chem [Internet] </span>1991;<span class="ref-vol">266</span>:24684–24689.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1722212" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem+[Internet]&amp;title=Cloning,+sequence,+and+developmental+expression+of+a+type+5,+tartrate-resistant,+acid+phosphatase+of+rat+bone&amp;author=B+Ek-Rylander&amp;author=P+Bill&amp;author=M+Norg&#x000e5;rd&amp;author=S+Nilsson&amp;author=G+Andersson&amp;volume=266&amp;publication_year=1991&amp;pages=24684-24689&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR5">5. <span class="mixed-citation">Lord DK, Cross NC, Bevilacqua MA, Rider SH, Gorman PA, Groves AV, et al. Type 5 acid phosphatase. Sequence, expression and chromosomal localization of a differentiation-associated protein of the human macrophage. Eur J Biochem [Internet]. 1990; [cited 2015 Oct 18];189:287&#x02013;93. Available from: <a href="http://www.ncbi.nlm.nih.gov/pubmed/2338077" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.ncbi.nlm.nih.gov/pubmed/2338077</a> [<a href="https://pubmed.ncbi.nlm.nih.gov/2338077" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR6">6. <span class="element-citation">Hayman AR, Dryden AJ, Chambers TJ, Warburton MJ. Tartrate-resistant acid phosphatase from human osteoclastomas is translated as a single polypeptide. <span><span class="ref-journal">Biochem. J. [Internet] </span>1991;<span class="ref-vol">277</span>(Pt 3):631–634. doi: 10.1042/bj2770631.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1151288/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1872798" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1042%2Fbj2770631" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem.+J.+[Internet]&amp;title=Tartrate-resistant+acid+phosphatase+from+human+osteoclastomas+is+translated+as+a+single+polypeptide&amp;author=AR+Hayman&amp;author=AJ+Dryden&amp;author=TJ+Chambers&amp;author=MJ+Warburton&amp;volume=277&amp;issue=Pt+3&amp;publication_year=1991&amp;pages=631-634&amp;pmid=1872798&amp;doi=10.1042/bj2770631&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR7">7. <span class="mixed-citation">Ling P, Roberts RM. Uteroferrin and intracellular tartrate-resistant acid phosphatases are the products of the same gene. J. Biol. Chem. [Internet]. 1993; [cited 2015 Oct 18];268:6896&#x02013;902. Available from: <a href="http://www.ncbi.nlm.nih.gov/pubmed/8463220" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.ncbi.nlm.nih.gov/pubmed/8463220</a> [<a href="https://pubmed.ncbi.nlm.nih.gov/8463220" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR8">8. <span class="element-citation">Ek-Rylander B, Andersson G. Osteoclast migration on phosphorylated osteopontin is regulated by endogenous tartrate-resistant acid phosphatase. <span><span class="ref-journal">Exp Cell Res. </span>2010;<span class="ref-vol">316</span>:443–451. doi: 10.1016/j.yexcr.2009.10.019.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19854170" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.yexcr.2009.10.019" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Exp+Cell+Res&amp;title=Osteoclast+migration+on+phosphorylated+osteopontin+is+regulated+by+endogenous+tartrate-resistant+acid+phosphatase&amp;author=B+Ek-Rylander&amp;author=G+Andersson&amp;volume=316&amp;publication_year=2010&amp;pages=443-451&amp;pmid=19854170&amp;doi=10.1016/j.yexcr.2009.10.019&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR9">9. <span class="mixed-citation">An J, Briggs TA, Dumax-Vorzet A, Alarc&#x000f3;n-Riquelme ME, Belot A, Beresford M, et al. Tartrate-Resistant Acid Phosphatase Deficiency in the Predisposition to Systemic Lupus Erythematosus. Arthritis Rheumatol. 2016; [cited 2016 Jul 22]; (Hoboken, N.J.) [Internet]. Available from: <a href="http://www.ncbi.nlm.nih.gov/pubmed/27390188" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.ncbi.nlm.nih.gov/pubmed/27390188</a> [<a href="https://pubmed.ncbi.nlm.nih.gov/27390188" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR10">10. <span class="element-citation">Andersson G, Ek-Rylander B, Hollberg K, Ljusberg-Sj&#x000f6;Lander J, L&#x000e5;ng P, Norg&#x000e5;rd M, et al. TRACP as an Osteopontin Phosphatase. <span><span class="ref-journal">J Bone Miner Res [Internet] </span>2003;<span class="ref-vol">18</span>:1912–1915. doi: 10.1359/jbmr.2003.18.10.1912.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/14584906" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1359%2Fjbmr.2003.18.10.1912" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Bone+Miner+Res+[Internet]&amp;title=TRACP+as+an+Osteopontin+Phosphatase&amp;author=G+Andersson&amp;author=B+Ek-Rylander&amp;author=K+Hollberg&amp;author=J+Ljusberg-Sj&#x000f6;Lander&amp;author=P+L&#x000e5;ng&amp;volume=18&amp;publication_year=2003&amp;pages=1912-1915&amp;doi=10.1359/jbmr.2003.18.10.1912&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR11">11. <span class="element-citation">Lausch E, Janecke A, Bros M, Trojandt S, Alanay Y, De Laet C, et al. Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity. <span><span class="ref-journal">Nat Genet [Internet] </span>2011;<span class="ref-vol">43</span>:132–137. doi: 10.1038/ng.749.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21217752" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fng.749" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet+[Internet]&amp;title=Genetic+deficiency+of+tartrate-resistant+acid+phosphatase+associated+with+skeletal+dysplasia,+cerebral+calcifications+and+autoimmunity&amp;author=E+Lausch&amp;author=A+Janecke&amp;author=M+Bros&amp;author=S+Trojandt&amp;author=Y+Alanay&amp;volume=43&amp;publication_year=2011&amp;pages=132-137&amp;doi=10.1038/ng.749&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR12">12. <span class="element-citation">Capeller B, Caffier H, S&#x000fc;tterlin MW, Dietl J. Evaluation of tartrate-resistant acid phosphatase (TRAP) 5b as serum marker of bone metastases in human breast cancer. <span><span class="ref-journal">Anticancer Res [Internet] </span>2003;<span class="ref-vol">23</span>:1011–1015.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12820340" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Anticancer+Res+[Internet]&amp;title=Evaluation+of+tartrate-resistant+acid+phosphatase+(TRAP)+5b+as+serum+marker+of+bone+metastases+in+human+breast+cancer&amp;author=B+Capeller&amp;author=H+Caffier&amp;author=MW+S&#x000fc;tterlin&amp;author=J+Dietl&amp;volume=23&amp;publication_year=2003&amp;pages=1011-1015&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR13">13. <span class="element-citation">Chao TY, Wu YY, Janckila AJ. Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis. <span><span class="ref-journal">Clin Chim Acta. </span>2010;<span class="ref-vol">411</span>:1553–1564. doi: 10.1016/j.cca.2010.06.027.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20599857" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.cca.2010.06.027" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Chim+Acta&amp;title=Tartrate-resistant+acid+phosphatase+isoform+5b+(TRACP+5b)+as+a+serum+maker+for+cancer+with+bone+metastasis&amp;author=TY+Chao&amp;author=YY+Wu&amp;author=AJ+Janckila&amp;volume=411&amp;publication_year=2010&amp;pages=1553-1564&amp;pmid=20599857&amp;doi=10.1016/j.cca.2010.06.027&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR14">14. <span class="element-citation">Lyubimova NV, Pashkov MV, Tyulyandin SA, Gol&#x02019;dberg VE, Kushlinskii NE. Tartrate-resistant acid phosphatase as a marker of bone metastases in patients with breast cancer and prostate cancer. <span><span class="ref-journal">Bull Exp Biol Med. </span>2004;<span class="ref-vol">138</span>:77–79. doi: 10.1007/BF02694481.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15514730" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2FBF02694481" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bull+Exp+Biol+Med&amp;title=Tartrate-resistant+acid+phosphatase+as+a+marker+of+bone+metastases+in+patients+with+breast+cancer+and+prostate+cancer&amp;author=NV+Lyubimova&amp;author=MV+Pashkov&amp;author=SA+Tyulyandin&amp;author=VE+Gol&#x02019;dberg&amp;author=NE+Kushlinskii&amp;volume=138&amp;publication_year=2004&amp;pages=77-79&amp;pmid=15514730&amp;doi=10.1007/BF02694481&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR15">15. <span class="element-citation">Tauchert S, di Liberto A, Cordes T, Thill M, Salehin D, Friedrich M. Tartrate-resistant acid phosphatase (TRAP) as a serum marker for bone resorption in breast cancer patients with bone metastases. <span><span class="ref-journal">Clin Exp Obs Gynecol [Internet] </span>2009;<span class="ref-vol">36</span>:219–225.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20101852" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Obs+Gynecol+[Internet]&amp;title=Tartrate-resistant+acid+phosphatase+(TRAP)+as+a+serum+marker+for+bone+resorption+in+breast+cancer+patients+with+bone+metastases&amp;author=S+Tauchert&amp;author=A+di+Liberto&amp;author=T+Cordes&amp;author=M+Thill&amp;author=D+Salehin&amp;volume=36&amp;publication_year=2009&amp;pages=219-225&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR16">16. <span class="element-citation">Yao NS, Wu YY, Janckila AJ, Ku CH, Hsieh AT, Ho CL, et al. Serum tartrate-resistant acid phosphatase 5b (TRACP5b) activity as a biomarker for bone metastasis in non-small cell lung cancer patients. <span><span class="ref-journal">Clin Chim Acta. </span>2011;<span class="ref-vol">412</span>:181–185. doi: 10.1016/j.cca.2010.09.038.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20932965" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.cca.2010.09.038" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Chim+Acta&amp;title=Serum+tartrate-resistant+acid+phosphatase+5b+(TRACP5b)+activity+as+a+biomarker+for+bone+metastasis+in+non-small+cell+lung+cancer+patients&amp;author=NS+Yao&amp;author=YY+Wu&amp;author=AJ+Janckila&amp;author=CH+Ku&amp;author=AT+Hsieh&amp;volume=412&amp;publication_year=2011&amp;pages=181-185&amp;pmid=20932965&amp;doi=10.1016/j.cca.2010.09.038&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR17">17. <span class="element-citation">Adams LM, Warburton MJ, Hayman AR. Human breast cancer cell lines and tissues express tartrate-resistant acid phosphatase (TRAP) <span><span class="ref-journal">Cell Biol Int. </span>2007;<span class="ref-vol">31</span>:191–195. doi: 10.1016/j.cellbi.2006.09.022.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17088078" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.cellbi.2006.09.022" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Biol+Int&amp;title=Human+breast+cancer+cell+lines+and+tissues+express+tartrate-resistant+acid+phosphatase+(TRAP)&amp;author=LM+Adams&amp;author=MJ+Warburton&amp;author=AR+Hayman&amp;volume=31&amp;publication_year=2007&amp;pages=191-195&amp;pmid=17088078&amp;doi=10.1016/j.cellbi.2006.09.022&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR18">18. <span class="element-citation">Honig A, Rieger L, Kapp M, Krockenberger M, Eck M, Dietl J, et al. Increased tartrate-resistant acid phosphatase (TRAP) expression in malignant breast, ovarian and melanoma tissue: an investigational study. <span><span class="ref-journal">BMC Cancer [Internet] </span>2006;<span class="ref-vol">6</span>:199. doi: 10.1186/1471-2407-6-199.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1550422/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16869970" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1186%2F1471-2407-6-199" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Cancer+[Internet]&amp;title=Increased+tartrate-resistant+acid+phosphatase+(TRAP)+expression+in+malignant+breast,+ovarian+and+melanoma+tissue:+an+investigational+study&amp;author=A+Honig&amp;author=L+Rieger&amp;author=M+Kapp&amp;author=M+Krockenberger&amp;author=M+Eck&amp;volume=6&amp;publication_year=2006&amp;pages=199&amp;doi=10.1186/1471-2407-6-199&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR19">19. <span class="element-citation">Zenger S, He W, Ek-Rylander B, Vassiliou D, Wedin R, Bauer H, et al. Differential expression of tartrate-resistant acid phosphatase isoforms 5a and 5b by tumor and stromal cells in human metastatic bone disease. <span><span class="ref-journal">Clin Exp Metastasis [Internet] </span>2011;<span class="ref-vol">28</span>:65–73. doi: 10.1007/s10585-010-9358-4.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20967488" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs10585-010-9358-4" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Metastasis+[Internet]&amp;title=Differential+expression+of+tartrate-resistant+acid+phosphatase+isoforms+5a+and+5b+by+tumor+and+stromal+cells+in+human+metastatic+bone+disease&amp;author=S+Zenger&amp;author=W+He&amp;author=B+Ek-Rylander&amp;author=D+Vassiliou&amp;author=R+Wedin&amp;volume=28&amp;publication_year=2011&amp;pages=65-73&amp;doi=10.1007/s10585-010-9358-4&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR20">20. <span class="element-citation">Scott KL, Nogueira C, Heffernan TP, van Doorn R, Dhakal S, Hanna JA, et al. Proinvasion Metastasis Drivers in Early-Stage Melanoma Are Oncogenes. <span><span class="ref-journal">Cancer Cell [Internet] </span>2011;<span class="ref-vol">20</span>:92–103. doi: 10.1016/j.ccr.2011.05.025.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3176328/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21741599" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.ccr.2011.05.025" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Cell+[Internet]&amp;title=Proinvasion+Metastasis+Drivers+in+Early-Stage+Melanoma+Are+Oncogenes&amp;author=KL+Scott&amp;author=C+Nogueira&amp;author=TP+Heffernan&amp;author=R+van+Doorn&amp;author=S+Dhakal&amp;volume=20&amp;publication_year=2011&amp;pages=92-103&amp;doi=10.1016/j.ccr.2011.05.025&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR21">21. <span class="element-citation">Xia L, Huang W, Tian D, Chen Z, Zhang L, Li Y, et al. ACP5, a direct transcriptional target of FoxM1, promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma. <span><span class="ref-journal">Oncogene [Internet] </span>2014;<span class="ref-vol">33</span>:1395–1406. doi: 10.1038/onc.2013.90.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23604121" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fonc.2013.90" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene+[Internet]&amp;title=ACP5,+a+direct+transcriptional+target+of+FoxM1,+promotes+tumor+metastasis+and+indicates+poor+prognosis+in+hepatocellular+carcinoma&amp;author=L+Xia&amp;author=W+Huang&amp;author=D+Tian&amp;author=Z+Chen&amp;author=L+Zhang&amp;volume=33&amp;publication_year=2014&amp;pages=1395-1406&amp;doi=10.1038/onc.2013.90&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR22">22. <span class="element-citation">Kawamura M, Tanaka K, Toiyama Y, Okugawa Y, Okigami M, Yasuda H, et al. Clinical significance of tartrate-resistant acid phosphatase type-5 expression in human gastric cancer. <span><span class="ref-journal">Anticancer Res. [Internet] </span>2014;<span class="ref-vol">34</span>:3425–3429.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24982350" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Anticancer+Res.+[Internet]&amp;title=Clinical+significance+of+tartrate-resistant+acid+phosphatase+type-5+expression+in+human+gastric+cancer&amp;author=M+Kawamura&amp;author=K+Tanaka&amp;author=Y+Toiyama&amp;author=Y+Okugawa&amp;author=M+Okigami&amp;volume=34&amp;publication_year=2014&amp;pages=3425-3429&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR23">23. <span class="mixed-citation">Gao Y-L, Liu M-R, Yang S-X, Dong Y-J, Tan X-F. Prognostic significance of ACP5 expression in patients with lung adenocarcinoma. Clin Respir J [Internet]. 2017 [cited 2017 Apr 18]; Available from: <a href="http://doi.wiley.com/10.1111/crj.12637" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://doi.wiley.com/10.1111/crj.12637</a> [<a href="https://pubmed.ncbi.nlm.nih.gov/28398694" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR24">24. <span class="element-citation">Sheu T-J, Schwarz EM, Martinez DA, O&#x02019;Keefe RJ, Rosier RN, Zuscik MJ, et al. A phage display technique identifies a novel regulator of cell differentiation. <span><span class="ref-journal">J. Biol. Chem. [Internet] </span>2003;<span class="ref-vol">278</span>:438–443. doi: 10.1074/jbc.M208292200.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12403789" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1074%2Fjbc.M208292200" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Biol.+Chem.+[Internet]&amp;title=A+phage+display+technique+identifies+a+novel+regulator+of+cell+differentiation&amp;author=T-J+Sheu&amp;author=EM+Schwarz&amp;author=DA+Martinez&amp;author=RJ+O&#x02019;Keefe&amp;author=RN+Rosier&amp;volume=278&amp;publication_year=2003&amp;pages=438-443&amp;doi=10.1074/jbc.M208292200&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR25">25. <span class="element-citation">Metz-Estrella D, Jonason JH, Sheu TJ, Mroczek-Johnston RM, Puzas JE. TRIP-1: A regulator of osteoblast function. <span><span class="ref-journal">J Bone Miner Res [Internet] </span>2012;<span class="ref-vol">27</span>:1576–1584. doi: 10.1002/jbmr.1611.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3377841/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22460930" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1002%2Fjbmr.1611" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Bone+Miner+Res+[Internet]&amp;title=TRIP-1:+A+regulator+of+osteoblast+function&amp;author=D+Metz-Estrella&amp;author=JH+Jonason&amp;author=TJ+Sheu&amp;author=RM+Mroczek-Johnston&amp;author=JE+Puzas&amp;volume=27&amp;publication_year=2012&amp;pages=1576-1584&amp;doi=10.1002/jbmr.1611&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR26">26. <span class="element-citation">Patlaka C, Mai HA, L&#x000e5;ng P, Andersson G. The growth factor-like adipokine tartrate-resistant acid phosphatase 5a interacts with the rod G3 domain of adipocyte-produced nidogen-2. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2014;<span class="ref-vol">454</span>:446–452. doi: 10.1016/j.bbrc.2014.10.112.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25450682" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.bbrc.2014.10.112" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;title=The+growth+factor-like+adipokine+tartrate-resistant+acid+phosphatase+5a+interacts+with+the+rod+G3+domain+of+adipocyte-produced+nidogen-2&amp;author=C+Patlaka&amp;author=HA+Mai&amp;author=P+L&#x000e5;ng&amp;author=G+Andersson&amp;volume=454&amp;publication_year=2014&amp;pages=446-452&amp;pmid=25450682&amp;doi=10.1016/j.bbrc.2014.10.112&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR27">27. <span class="element-citation">Akhurst RJ, Derynck R. TGF-beta signaling in cancer-a double-edged sword. <span><span class="ref-journal">Trends Cell Biol [Internet] </span>2001;<span class="ref-vol">11</span>:S44–S51.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11684442" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Cell+Biol+[Internet]&amp;title=TGF-beta+signaling+in+cancer-a+double-edged+sword&amp;author=RJ+Akhurst&amp;author=R+Derynck&amp;volume=11&amp;publication_year=2001&amp;pages=S44-S51&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR28">28. <span class="element-citation">Derynck R, Akhurst RJ, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. <span><span class="ref-journal">Nat. Genet. [Internet] </span>2001;<span class="ref-vol">29</span>:117–129. doi: 10.1038/ng1001-117.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11586292" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fng1001-117" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Genet.+[Internet]&amp;title=TGF-beta+signaling+in+tumor+suppression+and+cancer+progression&amp;author=R+Derynck&amp;author=RJ+Akhurst&amp;author=A+Balmain&amp;volume=29&amp;publication_year=2001&amp;pages=117-129&amp;doi=10.1038/ng1001-117&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR29">29. <span class="mixed-citation">de Caestecker MP. Role of Transforming Growth Factor-beta Signaling in Cancer. J Natl Cancer Inst [Internet]. 2000;92:1388&#x02013;402. [cited 2016 Jun 8]; Available from: <a href="http://jnci.oxfordjournals.org/content/92/17/1388.full" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://jnci.oxfordjournals.org/content/92/17/1388.full</a> [<a href="https://pubmed.ncbi.nlm.nih.gov/10974075" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR30">30. <span class="mixed-citation">Wrana JL, Attisano L, Wieser R, Ventura F, Massagu&#x000e9; J. Mechanism of activation of the TGF-beta receptor. [Internet] Nature. 1994:341&#x02013;7. [cited 2016 Jun 8] Available from: <a href="http://www.nature.com/doifinder/10.1038/370341a0" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.nature.com/doifinder/10.1038/370341a0</a> [<a href="https://pubmed.ncbi.nlm.nih.gov/8047140" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR31">31. <span class="element-citation">Huang F, Chen Y-G. Regulation of TGF-&#x003b2; receptor activity. <span><span class="ref-journal">Cell Biosci [Internet] </span>2012;<span class="ref-vol">2</span>:9. doi: 10.1186/2045-3701-2-9.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3333473/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22420375" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1186%2F2045-3701-2-9" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Biosci+[Internet]&amp;title=Regulation+of+TGF-&#x003b2;+receptor+activity&amp;author=F+Huang&amp;author=Y-G+Chen&amp;volume=2&amp;publication_year=2012&amp;pages=9&amp;doi=10.1186/2045-3701-2-9&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR32">32. <span class="element-citation">Massagu&#x000e9; J. TGF&#x003b2; Signal Transduction. <span><span class="ref-journal">Annu Rev Biochem [Internet] </span>1998;<span class="ref-vol">67</span>:753–791. doi: 10.1146/annurev.biochem.67.1.753.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9759503" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1146%2Fannurev.biochem.67.1.753" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Biochem+[Internet]&amp;title=TGF&#x003b2;+Signal+Transduction&amp;author=J+Massagu&#x000e9;&amp;volume=67&amp;publication_year=1998&amp;pages=753-791&amp;doi=10.1146/annurev.biochem.67.1.753&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR33">33. <span class="element-citation">Morikawa M, Derynck R, Miyazono K. TGF-&#x003b2; and the TGF-&#x003b2; Family: Context-Dependent Roles in Cell and Tissue Physiology. <span><span class="ref-journal">Cold Spring Harb Perspect Biol [Internet] </span>2016;<span class="ref-vol">8</span>:a021873. doi: 10.1101/cshperspect.a021873.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4852809/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27141051" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1101%2Fcshperspect.a021873" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cold+Spring+Harb+Perspect+Biol+[Internet]&amp;title=TGF-&#x003b2;+and+the+TGF-&#x003b2;+Family:+Context-Dependent+Roles+in+Cell+and+Tissue+Physiology&amp;author=M+Morikawa&amp;author=R+Derynck&amp;author=K+Miyazono&amp;volume=8&amp;publication_year=2016&amp;pages=a021873&amp;doi=10.1101/cshperspect.a021873&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR34">34. <span class="element-citation">Wrighton KH, Lin X, Feng X-H. Phospho-control of TGF-beta superfamily signaling. <span><span class="ref-journal">Cell Res [Internet] </span>2009;<span class="ref-vol">19</span>:8–20. doi: 10.1038/cr.2008.327.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2929013/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19114991" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fcr.2008.327" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Res+[Internet]&amp;title=Phospho-control+of+TGF-beta+superfamily+signaling&amp;author=KH+Wrighton&amp;author=X+Lin&amp;author=X-H+Feng&amp;volume=19&amp;publication_year=2009&amp;pages=8-20&amp;doi=10.1038/cr.2008.327&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR35">35. <span class="mixed-citation">MacCallum J, Bartlett JMS, Thompson AM, Keen JC, Dixon JM, Miller WR. Expression of transforming growth factor beta mRNA isoforms in human breast cancer. Br J Cancer [Internet]. 1994;69:1006&#x02013;9. [cited 2016 Jun 10]; Available from: <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1969445/?tool=pmcentrez&#x00026;report=abstract" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1969445/?tool=pmcentrez&#x00026;report=abstract</a> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1969445/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8198961" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR36">36. <span class="element-citation">Walker RA, Dearing SJ. Transforming growth factor beta 1 in ductal carcinoma in situ and invasive carcinomas of the breast. <span><span class="ref-journal">Eur J Cancer [Internet] </span>1992;<span class="ref-vol">28</span>:641–644. doi: 10.1016/S0959-8049(05)80116-9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1317202" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2FS0959-8049(05)80116-9" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Cancer+[Internet]&amp;title=Transforming+growth+factor+beta+1+in+ductal+carcinoma+in+situ+and+invasive+carcinomas+of+the+breast&amp;author=RA+Walker&amp;author=SJ+Dearing&amp;volume=28&amp;publication_year=1992&amp;pages=641-644&amp;doi=10.1016/S0959-8049(05)80116-9&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR37">37. <span class="element-citation">Gorsch SM, Memoli VA, Stukel TA, Gold LI, Arrick BA. Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer. <span><span class="ref-journal">Cancer Res [Internet] </span>1992;<span class="ref-vol">52</span>:6949–6952.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1458485" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res+[Internet]&amp;title=Immunohistochemical+staining+for+transforming+growth+factor+beta+1+associates+with+disease+progression+in+human+breast+cancer&amp;author=SM+Gorsch&amp;author=VA+Memoli&amp;author=TA+Stukel&amp;author=LI+Gold&amp;author=BA+Arrick&amp;volume=52&amp;publication_year=1992&amp;pages=6949-6952&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR38">38. <span class="element-citation">Dave H, Trivedi S, Shah M, Shukla S. Transforming growth factor beta 2: a predictive marker for breast cancer. <span><span class="ref-journal">Indian J Exp Biol [Internet] </span>2011;<span class="ref-vol">49</span>:879–887.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22126020" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Indian+J+Exp+Biol+[Internet]&amp;title=Transforming+growth+factor+beta+2:+a+predictive+marker+for+breast+cancer&amp;author=H+Dave&amp;author=S+Trivedi&amp;author=M+Shah&amp;author=S+Shukla&amp;volume=49&amp;publication_year=2011&amp;pages=879-887&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR39">39. <span class="element-citation">Rod&#x000f3;n L, Gonz&#x000e0;lez-Junc&#x000e0; A, Del Mar IM, Sala-Hojman A, Mart&#x000ed;nez-S&#x000e1;ez E, Seoane J. Active CREB1 promotes a malignant TGFb2 autocrine loop in glioblastoma. <span><span class="ref-journal">Cancer Discov [Internet] </span>2014;<span class="ref-vol">4</span>:1230–1241. doi: 10.1158/2159-8290.CD-14-0275.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25084773" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1158%2F2159-8290.CD-14-0275" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Discov+[Internet]&amp;title=Active+CREB1+promotes+a+malignant+TGFb2+autocrine+loop+in+glioblastoma&amp;author=L+Rod&#x000f3;n&amp;author=A+Gonz&#x000e0;lez-Junc&#x000e0;&amp;author=IM+Del+Mar&amp;author=A+Sala-Hojman&amp;author=E+Mart&#x000ed;nez-S&#x000e1;ez&amp;volume=4&amp;publication_year=2014&amp;pages=1230-1241&amp;doi=10.1158/2159-8290.CD-14-0275&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR40">40. <span class="mixed-citation">Bourguignon LYW, Singleton PA, Zhu H, Zhou B. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells. J. Biol. Chem. [Internet]. 2002;277:39703&#x02013;12. [cited 2017 Mar 2]; Available from: <a href="http://www.jbc.org/cgi/content/short/277/42/39703" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.jbc.org/cgi/content/short/277/42/39703</a> [<a href="https://pubmed.ncbi.nlm.nih.gov/12145287" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR41">41. <span class="mixed-citation">Weber GF, Ashkar S, Glimcher MJ, Cantor H. Receptor-Ligand Interaction Between CD44 and Osteopontin (Eta-1). Science (80-. ). [Internet]. 1996;271:509&#x02013;12. Available from: <a href="http://science.sciencemag.org/content/271/5248/509" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://science.sciencemag.org/content/271/5248/509</a> [<a href="https://pubmed.ncbi.nlm.nih.gov/8560266" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR42">42. <span class="element-citation">Ek-Rylander B, Flores M, Wendel M, Heinegard D, Andersson G. Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro. <span><span class="ref-journal">J. Biol. Chem. [Internet] </span>1994;<span class="ref-vol">269</span>:14853–14856.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8195113" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Biol.+Chem.+[Internet]&amp;title=Dephosphorylation+of+osteopontin+and+bone+sialoprotein+by+osteoclastic+tartrate-resistant+acid+phosphatase.+Modulation+of+osteoclast+adhesion+in+vitro&amp;author=B+Ek-Rylander&amp;author=M+Flores&amp;author=M+Wendel&amp;author=D+Heinegard&amp;author=G+Andersson&amp;volume=269&amp;publication_year=1994&amp;pages=14853-14856&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR43">43. <span class="element-citation">Franz&#x000e9;n A, Heineg&#x000e5;rd D. Isolation and characterization of two sialoproteins present only in bone calcified matrix. <span><span class="ref-journal">Biochem. J. [Internet] </span>1985;<span class="ref-vol">232</span>:715–724. doi: 10.1042/bj2320715.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1152943/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/4091817" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1042%2Fbj2320715" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem.+J.+[Internet]&amp;title=Isolation+and+characterization+of+two+sialoproteins+present+only+in+bone+calcified+matrix&amp;author=A+Franz&#x000e9;n&amp;author=D+Heineg&#x000e5;rd&amp;volume=232&amp;publication_year=1985&amp;pages=715-724&amp;pmid=4091817&amp;doi=10.1042/bj2320715&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR44">44. <span class="mixed-citation">Ek-Rylander B, Barkhem T, Ljusberg J, Ohman L, Andersson KK, Andersson G. Comparative studies of rat recombinant purple acid phosphatase and bone tartrate-resistant acid phosphatase. Biochem. J. [Internet]. 1997;321(2):305&#x02013;11. Available from: <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1218069/?tool=pmcentrez" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1218069/?tool=pmcentrez</a> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1218069/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9020859" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR45">45. <span class="element-citation">Krumpel M, Reithmeier A, Senge T, Baeumler TA, Frank M, Nyholm PG, et al. The small chemical enzyme inhibitor 5-phenylnicotinic acid/CD13 inhibits cell migration and invasion of tartrate-resistant acid phosphatase/ACP5-overexpressing MDA-MB-231 breast cancer cells. <span><span class="ref-journal">Exp Cell Res [Internet] </span>2015;<span class="ref-vol">339</span>:154–162. doi: 10.1016/j.yexcr.2015.09.019.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26428664" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.yexcr.2015.09.019" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Exp+Cell+Res+[Internet]&amp;title=The+small+chemical+enzyme+inhibitor+5-phenylnicotinic+acid/CD13+inhibits+cell+migration+and+invasion+of+tartrate-resistant+acid+phosphatase/ACP5-overexpressing+MDA-MB-231+breast+cancer+cells&amp;author=M+Krumpel&amp;author=A+Reithmeier&amp;author=T+Senge&amp;author=TA+Baeumler&amp;author=M+Frank&amp;volume=339&amp;publication_year=2015&amp;pages=154-162&amp;doi=10.1016/j.yexcr.2015.09.019&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR46">46. <span class="element-citation">Zenger S, Ek-Rylander B, Andersson G. Biogenesis of tartrate-resistant acid phosphatase isoforms 5a and 5b in stably transfected MDA-MB-231 breast cancer epithelial cells. <span><span class="ref-journal">Biochim Biophys Acta - Mol Cell Res. </span>2010;<span class="ref-vol">1803</span>:598–607. doi: 10.1016/j.bbamcr.2010.01.021.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20149826" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.bbamcr.2010.01.021" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochim+Biophys+Acta+-+Mol+Cell+Res&amp;title=Biogenesis+of+tartrate-resistant+acid+phosphatase+isoforms+5a+and+5b+in+stably+transfected+MDA-MB-231+breast+cancer+epithelial+cells&amp;author=S+Zenger&amp;author=B+Ek-Rylander&amp;author=G+Andersson&amp;volume=1803&amp;publication_year=2010&amp;pages=598-607&amp;doi=10.1016/j.bbamcr.2010.01.021&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR47">47. <span class="element-citation">Branca RMM, Orre LM, Johansson HJ, Granholm V, Huss M, P&#x000e9;rez-Bercoff &#x000c5;, et al. HiRIEF LC-MS enables deep proteome coverage and unbiased proteogenomics. <span><span class="ref-journal">Nat Methods [Internet] </span>2014;<span class="ref-vol">11</span>:59–62. doi: 10.1038/nmeth.2732.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24240322" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fnmeth.2732" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Methods+[Internet]&amp;title=HiRIEF+LC-MS+enables+deep+proteome+coverage+and+unbiased+proteogenomics&amp;author=RMM+Branca&amp;author=LM+Orre&amp;author=HJ+Johansson&amp;author=V+Granholm&amp;author=M+Huss&amp;volume=11&amp;publication_year=2014&amp;pages=59-62&amp;doi=10.1038/nmeth.2732&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR48">48. <span class="element-citation">Muller JW. Possible advantages of a robust evaluation of comparisons. <span><span class="ref-journal">J Res Natl Inst Stand Technol [Internet] </span>2000;<span class="ref-vol">105</span>:551. doi: 10.6028/jres.105.044.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4877159/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27551622" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.6028%2Fjres.105.044" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Res+Natl+Inst+Stand+Technol+[Internet]&amp;title=Possible+advantages+of+a+robust+evaluation+of+comparisons&amp;author=JW+Muller&amp;volume=105&amp;publication_year=2000&amp;pages=551&amp;doi=10.6028/jres.105.044&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR49">49. <span class="element-citation">Hsu PP, Kang SA, Rameseder J, Zhang Y, Ottina KA, Lim D, et al. The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling. <span><span class="ref-journal">Science (80-. ). [Internet] </span>2011;<span class="ref-vol">332</span>:1317–1322. doi: 10.1126/science.1199498.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3177140/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21659604" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1126%2Fscience.1199498" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science+(80-.+).+[Internet]&amp;title=The+mTOR-Regulated+Phosphoproteome+Reveals+a+Mechanism+of+mTORC1-Mediated+Inhibition+of+Growth+Factor+Signaling&amp;author=PP+Hsu&amp;author=SA+Kang&amp;author=J+Rameseder&amp;author=Y+Zhang&amp;author=KA+Ottina&amp;volume=332&amp;publication_year=2011&amp;pages=1317-1322&amp;doi=10.1126/science.1199498&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR50">50. <span class="element-citation">Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The Protein Kinase Complement of the Human Genome. <span><span class="ref-journal">Science (80-. ). [Internet] </span>2002;<span class="ref-vol">298</span>:1912–1934. doi: 10.1126/science.1075762.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12471243" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1126%2Fscience.1075762" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science+(80-.+).+[Internet]&amp;title=The+Protein+Kinase+Complement+of+the+Human+Genome&amp;author=G+Manning&amp;author=DB+Whyte&amp;author=R+Martinez&amp;author=T+Hunter&amp;author=S+Sudarsanam&amp;volume=298&amp;publication_year=2002&amp;pages=1912-1934&amp;doi=10.1126/science.1075762&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR51">51. <span class="element-citation">Duan G, Li X, K&#x000f6;hn M. The human DEPhOsphorylation database DEPOD: A 2015 update. <span><span class="ref-journal">Nucleic Acids Res. </span>2015;<span class="ref-vol">43</span>:D531–D535. doi: 10.1093/nar/gku1009.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4383878/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25332398" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1093%2Fnar%2Fgku1009" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Res&amp;title=The+human+DEPhOsphorylation+database+DEPOD:+A+2015+update&amp;author=G+Duan&amp;author=X+Li&amp;author=M+K&#x000f6;hn&amp;volume=43&amp;publication_year=2015&amp;pages=D531-D535&amp;pmid=25332398&amp;doi=10.1093/nar/gku1009&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR52">52. <span class="element-citation">Barrera LA, Vedenko A, Kurland JV, Rogers JM, Gisselbrecht SS, Rossin EJ, et al. Survey of variation in human transcription factors reveals prevalent DNA binding changes. <span><span class="ref-journal">Science (80-. ). [Internet] </span>2016;<span class="ref-vol">351</span>:1450–1454. doi: 10.1126/science.aad2257.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4825693/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27013732" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1126%2Fscience.aad2257" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science+(80-.+).+[Internet]&amp;title=Survey+of+variation+in+human+transcription+factors+reveals+prevalent+DNA+binding+changes&amp;author=LA+Barrera&amp;author=A+Vedenko&amp;author=JV+Kurland&amp;author=JM+Rogers&amp;author=SS+Gisselbrecht&amp;volume=351&amp;publication_year=2016&amp;pages=1450-1454&amp;doi=10.1126/science.aad2257&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR53">53. <span class="element-citation">Chen H-F, Wang J-K. The databases of transcription factors. <span><span class="ref-journal">Yi Chuan. </span>2010;<span class="ref-vol">32</span>:1009–1017. doi: 10.3724/SP.J.1005.2010.01009.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20943488" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3724%2FSP.J.1005.2010.01009" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Yi+Chuan&amp;title=The+databases+of+transcription+factors&amp;author=H-F+Chen&amp;author=J-K+Wang&amp;volume=32&amp;publication_year=2010&amp;pages=1009-1017&amp;pmid=20943488&amp;doi=10.3724/SP.J.1005.2010.01009&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR54">54. <span class="element-citation">Vaquerizas JM, Kummerfeld SK, Teichmann SA, Luscombe NM. A census of human transcription factors: function, expression and evolution. <span><span class="ref-journal">Nat Rev Genet. </span>2009;<span class="ref-vol">10</span>:252–263. doi: 10.1038/nrg2538.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19274049" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fnrg2538" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Genet&amp;title=A+census+of+human+transcription+factors:+function,+expression+and+evolution&amp;author=JM+Vaquerizas&amp;author=SK+Kummerfeld&amp;author=SA+Teichmann&amp;author=NM+Luscombe&amp;volume=10&amp;publication_year=2009&amp;pages=252-263&amp;pmid=19274049&amp;doi=10.1038/nrg2538&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR55">55. <span class="mixed-citation">Gao T, Liu Z, Wang Y, Cheng H, Yang Q, Guo A, et al. UUCD: A family-based database of ubiquitin and ubiquitin-like conjugation. Nucleic Acids Res. [Internet]. 2013;41. Available from: <a href="http://uucd.biocuckoo.org/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://uucd.biocuckoo.org/</a> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3531133/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23172288" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR56">56. <span class="element-citation">Hornbeck PV, Zhang B, Murray B, Kornhauser JM, Latham V, Skrzypek E. PhosphoSitePlus, 2014: Mutations, PTMs and recalibrations. <span><span class="ref-journal">Nucleic Acids Res. </span>2015;<span class="ref-vol">43</span>:D512–D520. doi: 10.1093/nar/gku1267.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4383998/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25514926" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1093%2Fnar%2Fgku1267" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Res&amp;title=PhosphoSitePlus,+2014:+Mutations,+PTMs+and+recalibrations&amp;author=PV+Hornbeck&amp;author=B+Zhang&amp;author=B+Murray&amp;author=JM+Kornhauser&amp;author=V+Latham&amp;volume=43&amp;publication_year=2015&amp;pages=D512-D520&amp;pmid=25514926&amp;doi=10.1093/nar/gku1267&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR57">57. <span class="element-citation">Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. <span><span class="ref-journal">Nucleic Acids Res [Internet] </span>2015;<span class="ref-vol">43</span>:D447–D452. doi: 10.1093/nar/gku1003.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4383874/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25352553" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1093%2Fnar%2Fgku1003" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Res+[Internet]&amp;title=STRING+v10:+protein-protein+interaction+networks,+integrated+over+the+tree+of+life&amp;author=D+Szklarczyk&amp;author=A+Franceschini&amp;author=S+Wyder&amp;author=K+Forslund&amp;author=D+Heller&amp;volume=43&amp;publication_year=2015&amp;pages=D447-D452&amp;doi=10.1093/nar/gku1003&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR58">58. <span class="element-citation">Panizza E, Branca RMM, Oliviusson P, Orre LM, Lehti&#x000f6; J. Isoelectric point-based fractionation by HiRIEF coupled to LC-MS allows for in-depth quantitative analysis of the phosphoproteome. <span><span class="ref-journal">Sci Rep. </span>2017;<span class="ref-vol">7</span>:4513. doi: 10.1038/s41598-017-04798-z.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5495806/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28674419" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41598-017-04798-z" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci+Rep&amp;title=Isoelectric+point-based+fractionation+by+HiRIEF+coupled+to+LC-MS+allows+for+in-depth+quantitative+analysis+of+the+phosphoproteome&amp;author=E+Panizza&amp;author=RMM+Branca&amp;author=P+Oliviusson&amp;author=LM+Orre&amp;author=J+Lehti&#x000f6;&amp;volume=7&amp;publication_year=2017&amp;pages=4513&amp;pmid=28674419&amp;doi=10.1038/s41598-017-04798-z&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR59">59. <span class="element-citation">Feder D, Hussein WM, Clayton DJ, Kan MW, Schenk G, McGeary RP, et al. Identification of Purple Acid Phosphatase Inhibitors by Fragment-Based Screening: Promising New Leads for Osteoporosis Therapeutics. <span><span class="ref-journal">Chem Biol Drug Des. </span>2012;<span class="ref-vol">80</span>:665–674. doi: 10.1111/cbdd.12001.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22943065" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1111%2Fcbdd.12001" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chem+Biol+Drug+Des&amp;title=Identification+of+Purple+Acid+Phosphatase+Inhibitors+by+Fragment-Based+Screening:+Promising+New+Leads+for+Osteoporosis+Therapeutics&amp;author=D+Feder&amp;author=WM+Hussein&amp;author=DJ+Clayton&amp;author=MW+Kan&amp;author=G+Schenk&amp;volume=80&amp;publication_year=2012&amp;pages=665-674&amp;pmid=22943065&amp;doi=10.1111/cbdd.12001&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR60">60. <span class="element-citation">Bazer FW, Worthington-White D, Fliss MF, Gross S. Uteroferrin: a progesterone-induced hematopoietic growth factor of uterine origin. <span><span class="ref-journal">Exp Hematol [Internet] </span>1991;<span class="ref-vol">19</span>:910–915.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1893968" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Exp+Hematol+[Internet]&amp;title=Uteroferrin:+a+progesterone-induced+hematopoietic+growth+factor+of+uterine+origin&amp;author=FW+Bazer&amp;author=D+Worthington-White&amp;author=MF+Fliss&amp;author=S+Gross&amp;volume=19&amp;publication_year=1991&amp;pages=910-915&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR61">61. <span class="element-citation">Simpson KJ, Selfors LM, Bui J, Reynolds A, Leake D, Khvorova A, et al. Identification of genes that regulate epithelial cell migration using an siRNA screening approach. <span><span class="ref-journal">Nat Cell Biol [Internet] </span>2008;<span class="ref-vol">10</span>:1027–1038. doi: 10.1038/ncb1762.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19160483" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fncb1762" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Cell+Biol+[Internet]&amp;title=Identification+of+genes+that+regulate+epithelial+cell+migration+using+an+siRNA+screening+approach&amp;author=KJ+Simpson&amp;author=LM+Selfors&amp;author=J+Bui&amp;author=A+Reynolds&amp;author=D+Leake&amp;volume=10&amp;publication_year=2008&amp;pages=1027-1038&amp;doi=10.1038/ncb1762&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR62">62. <span class="mixed-citation">Briggs TA, Rice GI, Daly S, Urquhart J, Gornall H, Bader-Meunier B, et al. Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature. Nat Genet [Internet]. 2011;43:127&#x02013;31. [cited 2017 Sept 4]; Available from: <a href="http://www.ncbi.nlm.nih.gov/pubmed/21217755" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.ncbi.nlm.nih.gov/pubmed/21217755</a> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3030921/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21217755" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR63">63. <span class="element-citation">Chellaiah M, Hruska K. The integrin alpha(v)beta(3) and CD44 regulate the actions of osteopontin on osteoclast motility. <span><span class="ref-journal">Calcif Tissue Int [Internet] </span>2003;<span class="ref-vol">72</span>:197–205. doi: 10.1007/s00223-002-1025-6.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12469249" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs00223-002-1025-6" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Calcif+Tissue+Int+[Internet]&amp;title=The+integrin+alpha(v)beta(3)+and+CD44+regulate+the+actions+of+osteopontin+on+osteoclast+motility&amp;author=M+Chellaiah&amp;author=K+Hruska&amp;volume=72&amp;publication_year=2003&amp;pages=197-205&amp;doi=10.1007/s00223-002-1025-6&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR64">64. <span class="element-citation">B&#x000f6;ttinger EP, Jakubczak JL, Roberts ISD, Mumy M, Hemmati P, Bagnall K, et al. Expression of a dominant-negative mutant TGF-&#x003b2; type II receptor in transgenic mice reveals essential roles for TGF-&#x003b2; in regulation of growth and differentiation in the exocrine pancreas. <span><span class="ref-journal">EMBO J [Internet] </span>1997;<span class="ref-vol">16</span>:2621–2633. doi: 10.1093/emboj/16.10.2621.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1169873/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9184209" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1093%2Femboj%2F16.10.2621" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=EMBO+J+[Internet]&amp;title=Expression+of+a+dominant-negative+mutant+TGF-&#x003b2;+type+II+receptor+in+transgenic+mice+reveals+essential+roles+for+TGF-&#x003b2;+in+regulation+of+growth+and+differentiation+in+the+exocrine+pancreas&amp;author=EP+B&#x000f6;ttinger&amp;author=JL+Jakubczak&amp;author=ISD+Roberts&amp;author=M+Mumy&amp;author=P+Hemmati&amp;volume=16&amp;publication_year=1997&amp;pages=2621-2633&amp;doi=10.1093/emboj/16.10.2621&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR65">65. <span class="element-citation">Halder SK, Beauchamp RD, Datta PK. A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers. <span><span class="ref-journal">Neoplasia [Internet] </span>2005;<span class="ref-vol">7</span>:509–521. doi: 10.1593/neo.04640.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1501161/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15967103" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1593%2Fneo.04640" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neoplasia+[Internet]&amp;title=A+specific+inhibitor+of+TGF-beta+receptor+kinase,+SB-431542,+as+a+potent+antitumor+agent+for+human+cancers&amp;author=SK+Halder&amp;author=RD+Beauchamp&amp;author=PK+Datta&amp;volume=7&amp;publication_year=2005&amp;pages=509-521&amp;doi=10.1593/neo.04640&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR66">66. <span class="mixed-citation">Liu X, Sun Y, Constantinescu SN, Karam E, Weinberg RA, Lodish HF. Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc Natl Acad Sci U S A [Internet]. 1997;94:10669&#x02013;74. [cited 2016 Jun 8]; Available from: <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC23442/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC23442/</a> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC23442/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9380693" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR67">67. <span class="element-citation">Morton DM, Barrack ER. Modulation of transforming growth factor beta 1 effects on prostate cancer cell proliferation by growth factors and extracellular matrix. <span><span class="ref-journal">Cancer Res [Internet] </span>1995;<span class="ref-vol">55</span>:2596–2602.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7780974" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res+[Internet]&amp;title=Modulation+of+transforming+growth+factor+beta+1+effects+on+prostate+cancer+cell+proliferation+by+growth+factors+and+extracellular+matrix&amp;author=DM+Morton&amp;author=ER+Barrack&amp;volume=55&amp;publication_year=1995&amp;pages=2596-2602&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR68">68. <span class="mixed-citation">Farina AR, Coppa A, Tiberio A, Tacconelli A, Turco A, Colletta G, et al. Transforming growth factor-beta1 enhances the invasiveness of human MDA- MB-231 breast cancer cells by up-regulating urokinase activity. Int J Cancer. Wiley Subscription Services, Inc., A Wiley Company; 1998;75:721&#x02013;30. [<a href="https://pubmed.ncbi.nlm.nih.gov/9495240" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR69">69. <span class="element-citation">Oft M, Heider K-H, Beug H. TGF&#x003b2; signaling is necessary for carcinoma cell invasiveness and metastasis. <span><span class="ref-journal">Curr Biol [Internet] </span>1998;<span class="ref-vol">8</span>:1243–1252. doi: 10.1016/S0960-9822(07)00533-7.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9822576" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2FS0960-9822(07)00533-7" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Biol+[Internet]&amp;title=TGF&#x003b2;+signaling+is+necessary+for+carcinoma+cell+invasiveness+and+metastasis&amp;author=M+Oft&amp;author=K-H+Heider&amp;author=H+Beug&amp;volume=8&amp;publication_year=1998&amp;pages=1243-1252&amp;doi=10.1016/S0960-9822(07)00533-7&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR70">70. <span class="element-citation">Mima K, Okabe H, Ishimoto T, Hayashi H, Nakagawa S, Kuroki H, et al. CD44s regulates the TGFbeta-mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma. <span><span class="ref-journal">Cancer Res. [Internet] </span>2012;<span class="ref-vol">72</span>:3414–3423. doi: 10.1158/0008-5472.CAN-12-0299.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22552294" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1158%2F0008-5472.CAN-12-0299" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res.+[Internet]&amp;title=CD44s+regulates+the+TGFbeta-mediated+mesenchymal+phenotype+and+is+associated+with+poor+prognosis+in+patients+with+hepatocellular+carcinoma&amp;author=K+Mima&amp;author=H+Okabe&amp;author=T+Ishimoto&amp;author=H+Hayashi&amp;author=S+Nakagawa&amp;volume=72&amp;publication_year=2012&amp;pages=3414-3423&amp;doi=10.1158/0008-5472.CAN-12-0299&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR71">71. <span class="element-citation">Ouhtit A, Madani S, Gupta I, Shanmuganathan S, Abdraboh ME, Al-Riyami H, et al. TGFbeta2: A novel target of CD44-promoted breast cancer invasion. <span><span class="ref-journal">J Cancer [Internet] </span>2013;<span class="ref-vol">4</span>:566–572. doi: 10.7150/jca.6638.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3753531/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23983821" ref="reftype=pubmed&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.7150%2Fjca.6638" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cancer+[Internet]&amp;title=TGFbeta2:+A+novel+target+of+CD44-promoted+breast+cancer+invasion&amp;author=A+Ouhtit&amp;author=S+Madani&amp;author=I+Gupta&amp;author=S+Shanmuganathan&amp;author=ME+Abdraboh&amp;volume=4&amp;publication_year=2013&amp;pages=566-572&amp;doi=10.7150/jca.6638&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR72">72. <span class="element-citation">Zhang Y, Tripathi V, Sixt K, Heller M. TGF-beta Regulates Alternative Splicing of CD44 by Inducing Smad3 Binding to CD44 pre-mRNA. <span><span class="ref-journal">FASEB J [Internet] </span>2015;<span class="ref-vol">29</span>:562.15.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=FASEB+J+[Internet]&amp;title=TGF-beta+Regulates+Alternative+Splicing+of+CD44+by+Inducing+Smad3+Binding+to+CD44+pre-mRNA&amp;author=Y+Zhang&amp;author=V+Tripathi&amp;author=K+Sixt&amp;author=M+Heller&amp;volume=29&amp;publication_year=2015&amp;pages=562.15&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=5602878&amp;issue-id=282902&amp;journal-id=16&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">BMC Cancer</span> are provided here courtesy of <strong>BMC</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC5602878/pdf/12885_2017_Article_3616.pdf" class="int-view">PDF (3.1M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/5602878/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/5602878/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="5602878" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5602878%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="N8S7x2PgboJsYRZ0wwwr7vETUS67zRTUaDM1Y3sfUhoM81WkqFfDkMPpsgIKe0Wk">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5602878%2F&amp;text=Tartrate-resistant%20acid%20phosphatase%20(TRAP%2FACP5)%20promotes%20metastasis-related%20properties%20via%20TGF%003B22%2FT%003B2R%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5602878%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602878/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC5602878/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/28915803/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC5602878/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/28915803/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC5602878/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/5602878/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC5602878/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
